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Solution nuclear magnetic resonance (NMR) spectroscopy is a valuable analytical
technique that is nondestructive, highly reproducible, and relatively quick to identify and
quantify many chemical compounds. Quantitative NMR is a technique commonly used in many
medical applications such as drug analysis, metabolomics, and protein-nanoparticle (P-NP)
interactions. The most common technique used is the proton (1H) NMR experiment. The 1H
NMR analysis provides a quick snapshot of the interested compounds in solution. However, as
the compounds become more complex the spectrum becomes overpopulated.
This dissertation focuses on various quantitative NMR techniques applied to metabolic
and protein competition studies. Specifically, we investigated the effect of biochar on
Escherichia coli (E. coli) growth to provide insight on how the metabolic pathways were
influenced with the addition of biochar in the RPMI media. A 1H NMR spectrum was recorded at
various time points to monitor the metabolic changes over time as E. coli grew in the presence
and absence of biochar. The spectra were compared to an in-house metabolite library to identify
and quantify the metabolic changes in E. coli. To enhance our metabolic library analysis, we
utilized a pure shift analysis attached to the TOCSY pulse program to deconvolute spin systems

by using a second dimension for analysis. DIPSI-PSYCHE TOCSY was applied to investigate a
metabolite mixture sample and Streptococcus pneumoniae (S. pneumoniae) extracellular
metabolites to better resolve the spin systems that significantly overlap each other in the 1H
NMR spectra. Our novel approach suggests that adding a pure shift to the TOCSY pulse program
is extremely beneficial to investigate various metabolic profiles.
Finally, we investigated the protein competition to the AuNP surfaces using a 2D 1H-15N
HSQC pulse program. Specifically, we used 1H-15N HSQC technique to quantify the binding
capacity for each protein to the AuNP surface before we investigated the competition of two
proteins, GB3-Ubq (model protein mixture) or AM-R2ab (biofilm forming protein mixture) to
the surface. We also employed a model to study the kinetics of the protein competition to the
surface. Our model suggests that GB3-Ubq does not specifically behave kinetically but AMR2ab is strictly kinetically controlled.
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CHAPTER I
INTRODUCTION
1.1

Quantitative NMR Techniques
Quantitative nuclear magnetic resonance (NMR) is a valuable technique used in a wide

range of applications. Quantitative NMR is used for determining the alcohol content in various
liquors,1 drug analysis,2 metabolomics,3-8 and protein binding to nanoparticles (NPs).9-13 Solution
NMR spectroscopy is a valuable technique that is nondestructive, highly reproducible, and
provides a quick snapshot of what is occurring in the sample.14-18 NMR spectroscopy is used to
exploit the non-zero spin properties of nuclei (1H, 13C, and 15N) to determine chemical shifts,
linewidths, and relative intensities for the NMR-visible spin systems.9 Each nucleus had a unique
chemical shift depending on its local chemical environment;5 however, the number of nuclei
resonating at that unique chemical shift will influence the signal intensity.9 The linewidth relates
how quickly the nuclei relax (R2, s-1), and the linewidth is influenced by many factors such as
rotational correlation time (τc) of the protein or metabolite, local motion, and chemical
exchange.9 The protein or metabolite τc is significantly influenced by the adsorption to particles
due to the particle’s slower rotational diffusion resulting in a decreased signal intensity and
significant line broadening.9,18 The particle binding influences the nuclei’s chemical environment
through chemical exchange resulting in a chemical shift difference (Δν).9 One should note that
the linewidths of the protein or metabolites are not significantly broadened beyond detection
when interacting with the particle surfaces; however, the signals of the protein residues or
1

metabolites interacting with the particle surfaces significantly decrease in peak intensity. To
ensure that the chemical shift perturbation observed from the particle during binding, the buffer
of the sample and particle should be matched. In this dissertation, 1D and 2D quantitative NMR
techniques are used to explore bacterial metabolites and proteins interacting with various particle
surfaces.
1.1.1

1D Proton and Half-Filtered NMR Experiments
Proton (1H) NMR is a useful tool for identification and quantification of many

compounds since a 1H spectrum can be quickly obtained (within minutes) to provide an accurate
snapshot of what is occurring in the sample.5,19-21 The typical spectral width ranges from 0 to 10
ppm, yielding a spectrum with a reasonable separation of the different spin systems in a complex
mixture.5,19-21 The signal observed is used to quantify the concentration of metabolites or protein
interacting with the particle surface.
The most common 1D 1H NMR experiment for metabolomics studies is the 1D 1H
Nuclear Overhauser Effect Spectroscopy (NOESY) with a pre-saturation of the water signal,
discussed later on in this section (Fig. 1.1 A.).22-25 This pre-saturation will suppress the water
signal to enhance the detection of the metabolic compounds that have a significantly lower
concentration.22-24 A 1D NOESY experiment uses a long on and off resonance saturation period
to allow the spins coupled via the Nuclear Overhauser Effect (NOE) to reach a steady-state
equilibrium. A common 1D 1H NMR experiment to investigate protein-nanoparticle (P-NP)
interactions is the one-one echo experiment (Fig. 1.1 B.). One-one echo is extremely useful to
suppress water when measuring protein samples because the one-one echo selective excitation
sequence will place the magnetization associated with the protein amides in the transverse (x-y)
plane and leave water along the z-axis.26-28 The one-one echo requires a shorter delay, making
2

the experimental time to be significantly shorter (2-3 min) than the 1D NOESY (7-8 min) owing
to the lack of water presaturation. With the one-one echo pulse program, it requires a narrower
linewidth for the water resonance to prevent off-resonance distortion to the baseline of the
spectrum resulting in a poorer quality result.28 To calculate the concentration of the compounds,
the peak intensity is compared to an internal or external reference that has a known
concentration. Typically for biological systems and 1D 1H NMR experiments use an internal or
external reference made up of either sodium trimethylsilypropanesulfonate (DSS) or
trimethylsilylpropanoic acid (TMSP). Both reference compound resonant at 0 ppm and have very
little peak overlap, where most biological compounds do not have any resonances with a
chemical shift near 0 ppm.
As shown in Figure 1.1, the quality of the 1H NMR spectra can be easily compared. The
1D NOESY spectrum of RPMI media has resolved peaks making it easier to compare the
metabolite peaks to the metabolic library for identification and quantification (Fig. 1.1 A.). With
the presaturation added to the 1D NOESY, the water signal (4.7 ppm) is suppressed, increasing
the metabolite peak signal intensity for easier analysis. Without the pre-saturation added to the
pulse program, none of the metabolites downfield would be detected owing to the massive water
signal. The one-one echo spectrum of 500 μM R2ab exhibits an 180° phase difference between
the amide region (downfield) and aliphatic (upfield) of the water signal at 4.7 ppm (Fig. 1.1
B.).26 In the one-one echo experiment, the water signal is not fully suppressed like the 1D
NOESY, however, the water signal is reduced significantly to quantify the protein’s peak
intensity.

3

Figure 1.1

1D NOESY and One-One Echo Spectra.

A.) 1D NOESY spectrum with presaturation of RPMI media and B.) 1D one-one echo spectrum
of 500 μM R2ab.

4

Whether the method of choice is 1D NOESY or one-one echo for quantitative analysis,
there needs to be some type of water suppression in the sequence to reduce the water signal. As
previously mentioned, a presaturation is a common addition to the pulse program to suppress the
solvent, mainly water, to enhance the sample’s peak intensities to make it easier to monitor any
changes within the sample. Another common solvent suppression pulse sequence is the Watersuppression by Gradient-Tailored Excitation (WATERGATE).28-33 WATERGATE is a better
option for water suppression as it does not suppress signals from the nuclei that exchange with
the solvent.28-29,32-33 Without the water suppression, the signals from metabolites or proteins
would be buried under the large water signal. WATERGATE employs a relatively short
radiofrequency (RF) pulse that is typically not frequency-selective to give a wide excitation
minimum around the water signal.28-29,32-33 This wide excitation minimum around the water
signal influences those resonances near the water peak by reducing the signal.29
1.1.1.1

Metabolomics Quantitative NMR Experiments
Quantitative metabolomics studies provide insight on how bacterial metabolites and their

concentration are altered, which relates back to gene environment interactions.5,34-36 The
resolution of the 1H NMR spectrometer is sufficient to resolve the components of a complex
mixture containing numerous metabolites with little spectral overlap of constituent compounds.
1

H NMR spectroscopy provides a highly reproducible spectrum with minimal sample handling as

compared to mass spectrometry (MS) metabolomics studies.35 Typically for a metabolomics
study, the extracellular metabolites in the media are measured to gain insight in how the bacteria
utilized the metabolites. This includes both the uptake of nutrients such as glucose, adenine, and
asparagine, as well as the secretion of by-products and other metabolites.8,37-40 The

5

concentrations of the detected signals are calculated using the known concentration of TMSP in
the sample.
The metabolite concentrations are further analyzed using statistical analysis tools to
identify the differences between the groups (e.g. wild-type vs. mutant, untreated vs. treated
media, and healthy vs. diseased).41 These tools are beneficial to metabolomics studies since these
metabolites can be clustered to find the metabolites that are altered significantly between the
groups. Principal component analysis (PCA), a common statistical analysis tool, identifies the
statistical differences between the groups when individual compounds are investigated.7 Another
common statistical analysis tool in metabolomics studies is a heatmap. A heatmap is used to
visually represent the normalized, relative concentration in the groups by using a color scale,
where one color would represent a low or no concentration of a metabolite and another color
would represent a high concentration of metabolites.42 The heatmap helps identify patterns of the
extracellular metabolites by using a hierarchical clustering analysis to group the metabolites that
increase or decrease over time.43-45 Identifying the metabolites that are statistically different
provide insight into the metabolic pathway that is active or not active during the bacterial
growth. Thus, 1D 1H NMR based metabolomics studies are a valuable technique to investigate
the metabolic behavior of various bacterial strains under a controlled stress.
1.1.1.2

Protein-Nanoparticle Interactions Using NMR
The 1H NMR spectrum clearly distinguishes between amide (6-10 ppm) and aliphatic (0-

4.5 ppm) protons. The observed signal can be used to quantify the bound protein concentration to
the NP surface, where it is expected to observe a decrease in the peak intensity when NPs are
added to the sample.9 The NP’s slow rotational diffusion does influence line broadening.9 The
binding capacity of a protein to the NP surface is determined by titrating various concentrations
6

of NP (0-80 nM) to protein (20 μM). The decrease in signal intensity is related to the bound
protein concentration, where the bound protein concentration is plotted against the total NP
concentration, and the slope is used to estimate the binding capacity.9-10 A linear relationship
between bound protein concentration versus total NP concentration suggest that the NPs are
completely saturated with protein.10 The binding capacity reflects the total number of protein
molecules bound to the NP, no matter if the protein corona is a single layer or multiple layers on
the NP surface, or if the protein unfolds on the surface and becomes inactive provided very slow
exchange is observed.9 The binding capacity is determined using the protein fraction that is free
and does not interact with the NP surface (Equation 1.1).9-10 The protein fraction in solution (r, r
< 1), or the ratio of integrated signals, total protein concentration (CP), and the total nanoparticle
concentration (CNP) are used to calculate the number of protein bound per nanoparticles (N):
𝑁=

(1 − 𝑟)𝐶𝑃
𝐶𝑁𝑃

(1.1)

Even though the 1H NMR experiment provides direct structural information about the protein
bound to NP surface, the binding capacity determined using this method is in good correlation
with a predicted monolayer of folded protein on the surface of a 15 nm gold nanoparticle
(AuNP).10
The simple 1H NMR experiment is extremely useful to determine the binding capacity for
a single protein on the NP surface; however, it becomes challenging to understand how two
proteins will compete to bind to a NP surface using this approach. The simple 1H NMR
experiment would not be able to distinguish the two protons due to spectral overlap. A 1D halffilter NMR experiment is used to extend the 1H quantitative NMR experiments.9,46 For analysis,
three spectra are recorded: 1) no filter that is used for comparison with the external reference, 2)
7

a 13C-filter that is selective for the 13C attached protons, and 3) a 15N-filter that is selective for the
15

N attached protons. Similar to the 1H NMR experiment, a signal decrease is observed in the

presence of NP in solution. The half-filter NMR experiment allows for a quick and easy
monitoring of two proteins competing for the NP surface in situ.12 However for a mixture
containing three or more proteins, distinct isotope labelling is required along with the addition of
another filtered experiment to select for the additional isotopes, which are not already selected in
the filtered experiment (not 13C or 15N). This is where multidimensional approaches can be
useful as described next.
1.1.2

2D TOCSY and HSQC NMR Experiments
In 2D NMR experiments, chemical shifts are particularly sensitive to local chemical

environment and will significantly influence the peak chemical shift, linewidth, and intensity.5,9
2D NMR experiments can improve spectral resolution of a 1D 1H NMR experiment at the
expense of a longer experimental time, as well as heighten water suppression.4-5,47 This
improvement will reduce the crowding observed in the 1D 1H NMR spectrum of complex
samples.5,48 The most common 2D experiments in metabolomics and protein interaction studies
are the total correlation spectroscopy (TOCSY) and heteronuclear single-quantum coherence
(HSQC). These experiments provide beneficial information about the sample that could not be
obtained from the simple 1H NMR experiments. TOCSY experiments provide details about the
chemical shifts of all 1H spins within the same molecule or spin system resulting in cross-peaks
matching with the diagonal-peaks in the 1H-1H TOCSY spectrum (Fig. 1.2).5,49 TOCSY is a
valuable NMR technique that provides information about the resonances that belong to the same
molecule as the magnetization of one proton is transferred to a neighboring proton through bond
correlations creating these cross-peaks (Fig. 1.2). The HSQC experiment is a practical NMR
8

technique that obtains a 2D heteronuclear chemical shift correlation map between the directly
bound 1H and the heteronucleus (commonly 13C or 15N). The 1H-15N HSQC experiment provides
correlations between chemical shifts of the 1H spins directly attached to the 15N spins.5,50 Both
techniques are used to quantify metabolites and proteins interacting with various nanoparticles.
1.1.2.1

Metabolomics Quantitative NMR Experiments
As previously discussed, the 1H NMR experiment is extremely useful to quickly identify

and quantify the bacterial metabolites in a complex mixture. However, many of the metabolite
peaks tend to overlap in a highly crowded spectrum.5,48 Adding the second dimension in the
analysis, the magnetization is transferred between different nuclear spins allowing the spins to be
separated and better resolved. The magnetization transfer results in cross-peaks in the spectrum
that will connect peaks from the same compound to each other in the diagonal-peak.5 TOCSY
experiments are a viable alternative to studying metabolites, since TOCSY resolves the complete
spin-spin connectivity information for each molecular spin system, even for those metabolites
that are too low in concentration to be detected in the 1H-13C HSQC spectrum.51-52 This
alternative allows for spin systems from the same compound to be correlated and separate spin
systems that have similar chemical shifts.53 However, this method can still result in severe
overlapping as the 1H-1H scalar couplings results in multiplets in both dimensions (Fig. 1.2 A.).53
In figure 1.2 A., L-tryptophan has two distinct clusters in the TOCSY spectrum. The downfield
cluster contains the protons in the aromatic rings of L-tryptophan and the upfield cluster contains
the aliphatic protons between the rings and the carbonyl group. The dashed pink line and the
protons highlighted in the structure represent how the cross-peaks correlate to the diagonal-peaks
and how the magnetization is transferred through bond couplings (Fig. 1.2). The aromatic
protons in L-tryptophan are a good example in showing how TOCSY can easily separate spin
9

systems for each metabolite, yet the overlapping multiplets in both dimensions of the spectrum
make the identification challenging.
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Figure 1.2

2D Conventional TOCSY and DIPSI-PSYCHE TOCSY NMR Spectra.

A.) Conventional TOCSY and B.) DIPSI-PSYCHE TOCSY NMR of L-tryptophan. The pink
dotted line represents a bond correlation via spin-spin coupling within L-tryptophan represented
by the cross-peaks along the diagonal peaks. The pink H on the compound structure (insert)
represents the bond correlation via the spin-spin coupling that the dotted line represents in the
spectra.
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To overcome this severe crowding and overlapping in the spectrum, band-selective or
broadband homodecoupling methods can be introduced into the pulse sequence.53-55 One of the
most recent developments in broadband homodecoupling methods is the Pure Shift Yielded by
Chirp Excitation (PSYCHE).53-54,56-59 PSYCHE is more sensitive than the more common
broadband approaches such as bilinear rotation decoupling (BIRD) and Zangger-Sterk (ZS)
decoupling. PSYCHE, however, is only applied in the indirect (F1 or ω1) dimensions in the 2D
experiment.52-53,56-57,59-60 PSYCHE uses a low flip angle frequency-swept (“chirp”) pulses in the
presence of a field gradient to select a portion of the spins and suppress the passive spin
responses resulting in a singlet peak in the indirect dimension.60-61 Decoupling in the presence of
scalar interactions (DIPSI) schemes are used for isotropic mixing to ensure that the coherence
transfer is efficiently achieved over the chemical shift range. DIPSI ensures that the signal for
each spin system is maximized, and the weak sideband artifacts are minimized.55,62 DIPSIPSYCHE TOCSY results in an ultrahigh-resolution spectrum that resolves any spectral overlap,
which makes it easier to monitor the changes in metabolite concentration in complex mixtures
(Fig. 1.2 B.). In figure 1.2 B., the DIPSI-PSYCHE sequence is applied to the TOCSY pulse
sequence, where the protons in L-tryptophan are better resolved and the identification of each
cross-peak correlated back to the diagonal-peak is more clear. The aromatic protons in Ltryptophan are easily identified and the overlapping of the five aromatic protons are separated,
which affords the identification of each spin system (Fig. 1.2 B.).
1.1.2.2

Protein-Nanoparticle Interactions NMR Experiments
An 1H-15N HSQC spectrum of a protein monitors the amide region (15N), which results in

a spectrum that contains a fingerprint of the protein backbone (Fig. 1.3).9,63 This experiment
allows one to observe perturbations to the backbone amide nitrogen and proton chemical shifts,
12

linewidths, and intensities that occur when a protein interacts with a NP surfaces.9 Since the 1H15

N HSQC experiment is widely used to monitor the backbone interactions with NP surfaces,

proteins up to 35 kDa can be used for analysis.9,64 Larger proteins have a slower relaxation time
than τc making it difficult to measure and obtain a quality spectra for these systems without
losing signal for a significant number of residues and observing significant line broadening.
Transverse relaxation optimized spectroscopy (TROSY) is widely used to monitor the backbone
of larger proteins (70 to 80 kDa). However, TROSY methods are not able to overcome the
relaxation challenges encountered by proteins interacting with the NP surface.9,65-67
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Figure 1.3

2D HSQC NMR Spectrum.

Backbone amide 1H-15N HSQC experiment of 100 μM 15N-labeled Ubiquitin (Ubq) with 20 mM
15
N-Urea NMR insert as an external standard.
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As previously discussed in the 1H NMR section, 1H-15N HSQC experiments can be used
to quantitatively measure the binding capacity of NPs. The HSQC technique can correlate amino
acid residues to NP interactions. The amino acid residues binding to the NP surface will have
less relative signal intensity when NP are present in solution.9 Similar to the 1H NMR
experiment, the binding capacity can be determined by comparing the bound protein
concentration to the total NP concentration in solution. In this case, an external standard of 15Nurea is used to determine the relative concentration of the bound protein. 15N-Urea is selected as
the external standard since its resonance does not overlap with any of the protein 1H-15N
backbone resonances. The relative concentration is compared to the sample with no NPs and
with NPs to obtain absolute concentrations of protein binding to NPs surface.
An advantage to using 1H-15N HSQC experiments to monitor protein interactions with
NP surfaces is the simplicity of measuring protein competition of two distinct proteins with the
same isotopically labeled backbone. This method provides a spectrum that has spin systems
(resonances) with unique chemical shifts due to the local chemical environment that limits the
resonances that overlap each other.9 A traditional chemical shift perturbation is observed when
the chemical exchange is fast enough that the line broadening does not influence the peak
shape.9,68 However, this fast exchange limits the application to the soft corona because proteins
and nucleic acids are required to be weakly associated and in rapid exchange for these chemical
shift perturbations.9
1.2

Metabolomics Studies Interacting with Surfaces
Metabolomics is the study of small molecules that compose a network of metabolic

pathways, which provides key information on how the system interacts with the environment.5,36
MS and NMR techniques have been extensively used to study the metabolic pathways of
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numerous bacteria including E. coli,69-70 S. aureus,20,38 and S. pneumoniae.39,71 The most
commonly used technique to quantify metabolites is MS due to its high sensitivity and small
sample requirements. However, MS is destructive, less reproducible, and identifies major
compound fragments in the complex, metabolite sample.17 In comparison, NMR is a great tool to
quantify the extracellular metabolites of microorganisms due to its nondestructive, highly
reproducible, and quick analyses.8,17,20,37-40 As previously described in Section 1.1.1.1, 1D 1H
NMR experiments are typically used to identify and quantify metabolites in complex mixtures
with very little spectral overlap.51 However, the 1H NMR experiment has limitations on how
many metabolites can be analyzed together before the spectrum becomes overpopulated and
crowded making it a challenge to identify and quantify the metabolites of interest.72
To overcome this problem, charged nanoparticles have been added to complex media to
target metabolites binding to the NP surface. This target method will remove the metabolites that
interact with the NP surface from the solution and thereby the NMR spectra.18 The size, shape,
and charge of NP surfaces can be varied, but almost all NPs have a slow τc that is within the
microsecond range.18,73 As previously described in Section 1.1.1.2, this τc will significantly
decrease the peak intensity of the metabolites interacting with the NP surface, which will
simplify the observed metabolite 1H NMR spectrum. Zhang et al. investigated how charged
silica nanoparticles (SiNPs) enhanced the NMR spectrum resolution and metabolite
identification in urine.18 Using charged SiNPs reduces the spectral crowding in the 1H NMR
spectrum observed for a 10-metabolite mixture that had some spectral overlap upfield.18 The
metabolites that contain functional groups with opposite charges to those on the SiNP surface
were more likely to interact with the surface, leaving the molecules with the same charge or no
charge free in the extracellular media. This approach simplified the NMR spectrum and allowed
16

for straightforward identification of the metabolic NMR signals.18 This phenomena was
extremely beneficial for the metabolites that only had one or two cross-peaks in the HSQC
spectrum, such as methylguanidine or dimethylglycine.18
Not only have NPs been used to simplify the extracellular metabolites NMR spectrum,
NPs have been used to remove proteins from the complex mixture such as human serum. Serum
is rich in many molecular components, such as dissolved proteins, glucose, lipids, hormones,
antibodies, antigens, and metabolites, making it extremely challenging to monitor the metabolic
changes in human serum.74 Proteins have a large number of broad NMR peaks that overlap with
the resonances stemming from the metabolites.74 This protein overlap will introduce a distorted
baseline hindering the identification and quantification of metabolites in the serum media.74
Zhang et al. observed that adding SiNP to the serum sample will co-aggregate serum proteins
that can then be separated from the metabolic media through ultrafiltration.74 As previously
observed with the charged SiNP study, the NMR spectrum were simplified and better resolved
with the addition of SiNP to the metabolic media.
In metabolic studies, NPs have been widely used to simplify the NMR spectrum, where
understanding how NPs used in nanomedicines alter the metabolic pathways is beneficial to
optimize nanodrug delivery systems. For example, AuNPs were coated with chitosan or ceria to
monitor the metabolic response of human peripheral blood cells.75 Palomino-Schätzlein et al.
identified that the chitosan-coated AuNPs significantly increased the concentration of the
reduced form of glutathione, where cerium-coated AuNPs significantly altered several other
pathways.75 These physiological changes are related to the bodies goal of reducing how much
oxidant species are generated in the presence of cerium-coated AuNPs.75 The AuNPs stabilized
with ceria or chitosan systemically changed the metabolic profiles of the blood cells, revealing
17

that the antioxidant effect of the materials altered the metabolic pathways.75 This insight on how
the antioxidant effect of the ceria or chitosan coated AuNPs provide a mechanism of action and
side effects of new nanomedicines by optimizing how the AuNPs are used as an antioxidant for
blood cells.
Within the past few years, pharmaceutical companies have taken an interest in
nanomaterials for their drug delivery systems and imaging agents.76 These nanomaterials
compose of silver, gold, metal oxides, and graphene polymer-based materials have emerged as
an alternative antibacterial agent due to their small size and high surface-to-volume ratio.34,77-80
The advantages to using nanomaterials as an antibacterial agent is their low synthesis cost and
their size and surface charge are easily controlled.34,78 The composition of the NP core
significantly influences the metabolic pathway of the bacteria by the adsorbing metabolites in the
medium. This metabolite adsorption to the NP surface alters the available metabolites needed for
optimal bacterial growth and introduces a controlled environmental stress to the bacteria. For
example, Chatzimitakos and Stalikas observed that iron nanoparticles (FeNPs) did not inactivate
any of the metabolic pathways of interest, however, copper nanoparticles (CuNPs) and ironcopper nanoparticles (Fe-CuNPs) significantly limited the number of metabolites available to E.
coli and S. aureus.34,77 Silver nanoparticles (AgNPs) have antibacterial and antifungal properties
making AgNPs useful in pharmaceutical products as wound dressings and have been
increasingly incorporated into consumer goods such as textiles and cosmetics.9,76 Since NPs have
been widely used in medicine, NPs interacting and altering the metabolic pathways have gained
significant attention to optimize these medical applications to selectively target specific regions
of the cells.
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1.3

Protein-Nanoparticle Interactions
Over the past few decades, NPs have been applied in numerous research studies to

understand how NPs enhance medical and biotechnological fields due to their optical, electrical,
antibacterial, and antifungal properties.81-85 Many NPs, especially gold, silver, and silica NPs, are
easily synthesized, have a well-defined surface chemistry, and are non-toxic. These properties
make NPs ideal for medical applications including drug delivery, biosensing, and bioimaging.8186

When NPs are exposed to biological fluids, a biomolecular corona forms around the NP

surface. This biomolecular corona is composed of nucleic acids, lipids, and proteins that are
spontaneously competing for the surface until the corona reaches equilibrium.81-82,84,87-92 The
biomolecular corona will vary over time depending on the NP local environment – types of
tissues, protein concentrations, and lipid concentrations – as well as the size and charge of the
NP.87-88,91-94 To gain insight into the biomolecular corona formation on NP surfaces, proteins
interacting with NP surfaces are monitored to understand the driving force for the protein corona
formation, as well as understand the protein function once adsorbed to the NP surface.
The protein corona determines the ‘biological identity’ of the NP that contains
information about the interface formed between the NP and the biomolecule under the
physiological environment and is distinct from the NP’s ‘synthetic identity’.88 The corona is
classified in two regions: 1) the hard corona and 2) the soft corona. The hard corona is the innermost layer that consists of tightly bound proteins associated with the NP surface,87,95 whereas the
soft corona is the outer-most layer that consists of loosely bound proteins associated with the NP
surface that can freely interact with the environment before reaching equilibrium.95-97 The
evolution of the corona plays a key role in understanding the protein dynamics on the NP
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surface, which can be used to modify NP surfaces to specifically interact with biological systems
and enhance NP biological applications.
Quantifying P-NP interactions is important to gain insight in protein binding, dynamics,
and competition on the NP surfaces during the protein corona formation. Some proteins once
bound to the NP surfaces lose their function or unfold altering the NP and corona environment.98
Lundqvist et al. investigated human carbonic anhydrase I (HCA I) interactions with SiNPs and
found that the particle curvature strongly influenced the protein’s secondary structure, whereas
the change in the tertiary structure could not be correlated to the NP curvature.98 Woods et al.
also investigated how the particle curvature influenced the protein’s structure of GB3, BCA, and
drkN SH3, where AuNPs did not influence a change in protein structure for GB3 and BCA
adsorbed to the NP.13 However, the AuNPs influenced the protein stability of drkN SH3 by
allowing drkN SH3 to deform to have a higher binding capacity to the AuNPs surface.13 The NP
curvature affects a wide range of functions such as binding, catalytic enzymes turnover,
signaling and regulation, thermostability, rate of folding and unfolding, and aggregation of
proteins leading to neurodegenerative diseases.99 The electrostatic interactions between the
protein and NP significantly influence the binding selectivity, and this selectivity is highly
dependent on the NP surface charge distribution, topography, conformational flexibility, and
degree of hydration.93-94 The electrostatic interactions are an important physical force involved in
competitive binding due to the selective binding of the NP surface.12 Investigating the binding
adsorption and kinetics of the protein to the NP surface provides insight on how the protein
corona is formed and alters the NP surface local environment.
Exploring aspects of thermodynamic and kinetic control on P-NP interactions in
competition suggests that the NP surface characteristics may change over time influencing the
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binding. When a protein adsorbs to a large, bare NP surface, the protein binds through an
extended interface and undergoes a series of slow conformational rearrangements on the NP
surface to minimize their interfacial energy resulting in an irreversibly bound hard protein
corona.97,100-102 The rate (k2) at which the protein hardens on the NP surface is extremely fast and
not the rate-limiting step, the kinetic and the association reaction is characterized as the
diffusion-limit.100 The protein (P) will electrostatically interact with the NP surface that has a
kinetic on (k1) and off (k-1) rate between the aqueous media and the soft corona. Once this on and
off rate reaches equilibrium, the P will harden onto the NP surface (k2). A model for this
phenomenon is shown by Equation 1.2:
𝑘1
𝑘2
𝑃 + 𝑁𝑃 ⇌ (𝑃 − 𝑁𝑃)𝑆𝑜𝑓𝑡 𝐶𝑜𝑟𝑜𝑛𝑎 → (𝑃 − 𝑁𝑃)𝐻𝑎𝑟𝑑 𝐶𝑜𝑟𝑜𝑛𝑎
𝑘−1

(1.2)

As proteins adsorb to larger NPs (>3 nm), the protein bind through electrostatic interactions and
undergo a series of slow conformational rearrangements on the NP surface.100 These
conformational changes will minimize the interfacial energy resulting in the irreversible k2 rate
in the hard corona. Lira et al. observed that proteins interacting with ultrasmall NPs (<3 nm) can
reversibly bind from the hard corona to the soft corona because of the NPs size, the electrostatic
force is the prominent role in stabilizing the complex, and orientational constraints are
reduced.100
Protein competition on the NP surface will also significantly influence the local
environment of the NP and alter the net charge on the surface.100 The protein with the highest net
charge binds to the NP surface through electrostatic interactions. Over time, the protein corona
varies as the charge of the NP surface are altered when protein binds.12,100 The change in the
surface charge will influence the binding and kinetics of the next protein on the surface in the
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hard corona. Figure 1.4 shows that GB3 (gray) and Ubq (blue) will compete for the net
negatively charged SiNP surface. Once the soft corona reaches equilibrium, the two proteins are
kinetically favored to harden on the surface forming the hard corona (Fig. 1.4). Since both
proteins’ concentrations are equal (25 μM each for a Cp of 50 μM), a mixture of GB3 and Ubq
will bind in the hard corona (as observed in Fig. 1.4), where GB3 and Ubq are in equal parts on
the surface.
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Figure 1.4

Protein Competition onto Silica Nanoparticle Surface.

Competition between GB3 (gray) and Ubiquitin (blue) for silica nanoparticle (SiNP) surfaces.
The SiNP surface is composed of silanol groups, where some are protonated and others are
deprotonated yielding a net negative charge on the SiNP surface. A mixture of the protein will be
tightly bound to the SiNP surface in the hard corona, whereas the others will be loosely bound to
the SiNP surface in the soft corona interacting with the free proteins in the environment.
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1.4

Overview of Dissertation
Chapter 2. As mentioned above in Section 1.2, NPs significantly influence the metabolic

pathways of E. coli and S. aureus in the presence of CuNPs and Fe-CuNPs due to the adsorption
of many metabolites onto the NP surface. In this chapter, we build on this idea of NPs
influencing metabolic pathways by examining how larger particles, such as biochar (BC) and
activated carbon (AC), influence E. coli metabolism. It is hypothesized that with larger particle
sizes, the bacteria could readily adhere to the surface creating several bacterial colonies, which
could result in the formation of biofilm. This chapter outlines an experiment using BC or AC in a
complex media (RPMI) to monitor how E. coli alters the tricarboxylic acid (TCA) cycle in the
presence of these large particles in RPMI media. Using the 1D NOESY experiment, we will
identify and quantify how the metabolites change over time in the presence of these particles.
Similar to how the composition of the NP core can alter the metabolic pathway previously
described (Section 1.2), the composition of the particles’ surface significantly altered the
metabolic pathway of E. coli. We confirm that a smoother surface and a higher point of zero
charge favors metabolite electrostatic interactions to increase the adsorption capacity.
Chapter 3. As mentioned above in Section 1.1.2, the 1H NMR metabolomics studies are
beneficial for their fast analysis; however, the spectrum easily becomes crowded and
deconvoluting metabolic peaks becomes challenging. In this chapter, we build on the idea of
using 2D NMR methods for better peak separation and spectral resolution. We mainly focus on
using the 2D TOCSY method for our analysis since this method has enhanced sensitivity
compared to the HSQC method. Many metabolic studies that use HSQC experiments in their
analysis focus on the 1H-13C correlation, where 13C is not overly abundant (1.1% abundant). This
results in a less sensitive experiment requiring longer experimental timescale. Since TOCSY
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provides chemical shift details on all the proton spin systems within the same molecule, the
spectrum still remains crowded for analysis. In this chapter, we investigate the modification to
the TOCSY pulse program by applying a pure shift chirp (PSYCHE) to simplify the spectrum in
the indirect dimension. We show that this simplification makes identification of the metabolites
easier and more accurate. With the pure shift chirp applied in the indirect dimension, we find that
all the multiplets in the DIPSI-PSYCHE TOCSY experiments are averaged, significantly
simplifying the spin systems. This result leads for simpler identification of metabolite mixtures.
Chapter 4. As mentioned above in Section 1.3, P-NPs interactions have been widely
studied over the decades. In this chapter, we use a 2D quantitative NMR technique to study
protein binding competition onto an AuNP surface. Here, we focus on using a 1H-15N HSQC
technique to determine the binding capacity of GB3 and Ubq, the two model proteins used
previously in the lab to compare this 2D method to the original 1D method (one-one echo). We
confirmed that the HSQC method did not introduce any artifacts to the analysis and could be
used to further investigate protein competition. A series of protein mixtures were used to monitor
how varying the protein concentrations would affect the competition for the NP surface. We
tested the hypothesis that the protein competition onto AuNP surface is driven kinetically. In our
model protein competition, the competition is not just kinetically driven, as the observed binding
did not match the theoretical binding capacity and a simple model lacking any protein-protein
interactions. Here, Ubq binding data showed a sigmoidal dependence on the concentration of
GB3, where low concentrations of GB3 yielded a higher affinity of Ubq to bind to the NP
surface and a lower affinity of Ubq to bind to the NP surface in the presence of higher
concentrations of GB3. Whereas, GB3 binding data showed a convex shape, where Ubq might
be interacting with GB3 causing GB3 to deform before binding onto the NP surface. However,
25

we did confirm that in our biofilm forming protein, Amidase (AM) and R2ab, mixture
competition, the competition is kinetically driven where the binding of each protein is similar to
the theoretical values.
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CHAPTER II
EFFECT OF BIOCHAR ON MICROBIAL GROWTH: A METABOLOMICS AND
BACTERIOLOGICAL INVESTIGATION IN E. coli
Reprinted with permission from Hill, R.A.; Hunt, J.; Sanders, E.; Tran, M.; Burk, G.A.;
Mlsna, T.E.; and Fitzkee, N.C. Effect of Biochar on Microbial Growth: A Metabolomics and
Bacteriological Investigation in E. coli. Environmental Science and Technology 2019, 53 (5),
2635-2646. Copyright © 2019 American Chemical Society.
2.1

Abstract
Biochar has been proposed as a soil amendment in agricultural applications due to its

advantageous adsorptive properties, high porosity, and low cost. These properties allow biochar
to retain soil nutrients, yet the effects of biochar on bacterial growth remain poorly understood.
To examine how biochar influences microbial metabolism, Escherichia coli was grown in a
complex, well-defined media and treated with either biochar or activated carbon. The
concentration of metabolites in the media were then quantified at several time points using NMR
spectroscopy. Several metabolites were immediately adsorbed by the char, including Lasparagine, L-glutamine, and L-arginine. However, we find that biochar quantitatively adsorbs
less of these metabolic precursors when compared to activated carbon. Electron microscopy
reveals differences in surface morphology after cell culture, suggesting that Escherichia coli can
form biofilms on the surfaces of the biochar. An examination of significant compounds in the
tricarboxylic acid cycle and glycolysis reveals that treatment with biochar is less disruptive than
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activated carbon throughout metabolism. While both biochar and activated carbon slowed
growth compared to untreated media, Escherichia coli in biochar-treated media grew more
efficiently, as indicated by a longer logarithmic growth phase and a higher final cell density. This
work suggests that biochar’s adsorptive properties benefit soil amendment while minimizing the
impact on bacterial viability. In addition, the experiments identify a mechanism for biochar’s
effectiveness in soil conditioning and reveal how biochar can alter specific bacterial metabolic
pathways.
2.2

Introduction
Biochar (BC) is often produced from renewable organic waste that is converted to a

carbonaceous material through pyrolysis and it is comparatively cheaper than activated carbon
(AC).1-3 BC, a carbon source, is often used in agriculture as a soil additive due to its adsorptive
properties, porous surface, and low cost. BC improves soil fertility and structure, sequesters
carbon (mitigating climate change), and enriches beneficial soil microorganisms.4-9 BC’s
adsorptive properties vary with feedstock and pyrolysis conditions, which can be tailored for
optimal removal of specific chemicals, such as pesticides, phosphates, organic dyes, heavy
metals, and pharmaceuticals from waste water and soil.3,9-14
Previous studies have focused on bulk properties of soil after treatment with BC, rather
than focusing on the behavior of individual metabolites. These properties – pH, adsorption,
nitrogen content, etc. – can change how organisms grow in BC-treated soil. For example,
addition of BC to soil can alter metal mobility, either positively or negatively, depending on its
influence on soil pH and dissolved organic matter.3,11,13 BC adsorptive properties also improve
soil physical and chemical properties by increasing pH, aeration, and water holding
capacity.1,3,15-16 Moreover, BC has been shown to restore nutrients derived from feedstock by
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modulating cation exchange capacity (CEC), increasing specific surface areas, and influencing
hydrophobicity.10-11,17
Physical and chemical properties of BC increase net nitrogen mineralization, increase
nitrification, and enhance denitrification during microbial-mediated transformation of nutrients
in soil.11,18 Microbial activity itself is influenced by BC treatment. This has been linked to
nutrient and pH changes, as well as nitrogen transformations.10,15 BC-treated soil can also
influence microbial composition by enhancing plant’s growth and mineralization of the soil’s
organic carbon.11,15 While it is clear that BC can dramatically influence organisms in the soil by
altering soil properties, much less is known about how BC influences microbiota metabolism
itself. Presumably, this metabolic influence favors organisms that prefer basic growing
conditions or disfavors organisms that prefer acidic growing conditions, as the number of
organisms change with the addition of BC into the soil.11,15 BC is also effective in controlling
foliar and soil-borne pathogens, as well as showing a neutral or negative effect of BC on plant
pathogens.4-5,11,16
Understanding the metabolomics of soil microorganisms promises to enhance our
knowledge on BC’s influence in the microbial community. Metabolomics is the study of small
molecules that make up a network of metabolic pathways that provide key insight into geneenvironment interactions.19-20 Mass spectrometry (MS) and NMR techniques have been used
extensively to study metabolomics. In the metabolomics field, MS spectrometry is commonly
used because of the high sensitivity, detection of thousand metabolites in a single measurement,
and reliable metabolite identification through tandem mass analysis; however MS is less
reproducible, destructive to samples, and identities for a major fraction of detected metabolites
are not known.21 NMR spectroscopy is a useful tool to quantify the extracellular metabolites,
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since it is non-destructive, highly reproducible, and provides a snapshot of what is occurring in
the sample.21-27 The extracellular metabolites in the media were monitored to the uptake of
nutrients, such as glucose, adenine, and asparagine, as well as the accumulation of fermentation
products and other metabolites secreted by the bacterium.22-24,26-27 NMR spectroscopy monitors
and quantifies the more abundant compounds present in biological fluids, cell extracts, and
tissues without the need for sample extraction required by MS that can affect results, as well as
NMR can detect metabolites that are difficult to ionize by MS.21,28-30
Additionally, a 1D proton NMR spectrum is often sufficient for resolving the components
of a complex mixture with little overlap of the constituent compounds.31 The detected signals can
also be directly analyzed by statistical tools to identify different subgroups (i.e. healthy vs
diseased, untreated media vs treated media, etc.), eliminating the need to identify the chemical
components of the sample.32 Alternatively, other statistical tools, like principal component
analysis (PCA),33 can be used to identify chemical differences when individual compounds are
being investigated. Thus, NMR-based metabolomics is a mature and useful approach for
understanding the behavior of bacteria in the presence of BC.
In this model study, we treated RPMI, a complex, well-defined bacterial growth media,
with BC and AC and compared how E. coli grew in treated media versus untreated media. We
hypothesized that BC and AC would have similar effects on bacterial growth compared to
untreated RPMI media. In addition to comparing the different metabolomic profiles, statistical
analysis was used to highlight differences and similarities between the media types, and the
overall effect on bacterial growth rates was measured. BC and AC surface were characterized to
interpret the difference in the cell growth rates. Our results provide insight on how BC can
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support the development of microbiota, and they reveal a mechanism by which BC can influence
microbial populations in the soil.
2.3
2.3.1

Materials and Methods
Treatment of Media and Bacterial Preparation
E. coli (BL21(DE3), Ampicillin-resistance gene) was grown in RPMI 1640 medium with

L-glutamine (Fisher Scientific, Pittsburgh, USA) for the overnight stock culture and bacterial
growth. Biochar Supreme, LLC (Everson, WA), generously provided Douglas fir, Ultra-Rinsed
Black Owl biochar (BC). Auger-fed, chipped Douglas fir was placed into an air-fed updraft
gasifier at 900-1000 °C for 1-10 s.34-35 The particles were collected, washed with water several
times to remove fine particulates and impurities before dying at room temperature.34-35 The
biochar was sieved to a particulate size of 75-150 μm. In previous experiments, point of zero
charge (PZC), scanning electron microscopy (SEM), energy dispersive analysis by X-ray (EDX),
transmission electron microscopy (TEM) and energy dispersive X-ray spectroscopy (EDS), Xray photoelectron spectroscopy (XPS), X-ray powder diffraction (XRD), BET, and elemental
analysis were carried out on BC.34-36
Cultures were inoculated from a fresh plate of Luria-Bertani (LB) media, plus 100 μg/mL
ampicillin. The overnight stock culture was shaken for 12 h at 200 rpm at 37 °C. The final
optical density (O.D.) (Nanodrop One/Onec, ThermoFisher Scientific, Pittsburgh, USA) of the
overnight stock culture at 600 nm was 0.855. The O.D.600 was measured to assess the rate of
bacterial growth for the overnight stock culture, BC- or AC-treated media, and untreated RPMI
media. 5% (by weight, 1.25 g) BC or 5% (1.25 g) Norit Activated Carbon (AC) was added to 25
mL of RPMI media. The overnight stock culture was then divided equally into the three different
media (RPMI, BC, and AC media) to begin bacterial growth. In this set of experiments, bacteria
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grew in the presence of BC, AC, or untreated RPMI media throughout the time course (24 h) of
each experiment.
An additional set of experiments were performed where BC or AC was removed from
media before inoculation (Section A.1.1). For these experiments, 10% (by weight, 3.0 g) BC or
10% (by weight, 3.0 g) AC was added to 30 mL RPMI media. The weight-by-mass percentage
was doubled (5 to 10%) to allow more of the media to adsorb to the particles before filtering BC
or AC from RPMI media. It should be noted that doubling the weight-by-mass percentage did
not alter the growth rate of E. coli, as both growth rates for treated media were similar between
the two experiments. The media was placed in the floor shaker (Innova 43 Incubator Shaker
Series, New Brunswick Scientific, Edison, NJ) at 200 rpm at 25.0 °C for 24 h. This allowed
ample time for BC and AC to adsorb metabolites from the media in the absence of bacterial
growth. During this time, no significant growth was observed based on O.D. measurements.
After 24 h of shaking, the media was filtered through a 25 mm polyethersulfone (PES), 0.2 μm
sterile syringe filter. The pH for each media was measured and adjusted to have a starting pH of
7.5. The overnight stock culture was divided equally into the three filtered media to begin the
bacterial growth, and experiments were performed as those described above.
2.3.2

Bacterial Growth
To begin the bacterial growth, the overnight stock culture was diluted into the media.

From the 50 mL overnight stock culture, 15 mL each was transferred into separate flasks: one
containing 1.25 g of BC in 25 mL RPMI media, one containing 1.25 g of AC in 25 mL RPMI
media, and a control sample of 25 mL RPMI with no treatment. The flasks were swirled to mix
BC and AC into the media. For the filter experiments, 15 mL of the 50 mL overnight stock
culture was transferred into the separate flasks similarly described for the unfiltered experiments.
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In addition, 2 mL of media was transferred to a sterile microcentrifuge tube to represent the
sample before treatment. The media was returned to the shaker to continue incubation. The
average starting O.D.600 value for each flask was 0.285.
An aliquot of each sample was taken every 30 min for the first 3 h, every 3 h for the next
9 h, and the final aliquot was taken at 24 h. For each time point, 2 mL of sample was transferred
to sterile microcentrifuge tubes. All samples were placed on ice to slow the bacterial growth
allowing BC and AC to settle. After 5 min on ice, most of BC and AC had sedimented to the
bottom of the tube so that 300 μL of the sample could be carefully transferred to a second sterile
microcentrifuge tube. The sample was then diluted with 700 μL of filtered RPMI media to allow
for O.D.600 measurements in the 0.1 to 1.0 range. This was necessary to prevent BC and AC from
interfering with measurements of optical density. The sample was carefully mixed using the
pipette tip and then transferred to a 1 cm cuvette. The O.D.600 was measured for each time point
to monitor the bacterial growth.
2.3.3

NMR Sample Preparation
The remaining aliquot of each sample was centrifuged at 21,000 x g for 12 min in

preparation for NMR spectroscopy. After centrifugation, the samples were sterile filtered and
400 μL of the supernatant was transferred to another clean, sterile microcentrifuge tube. 200 μL
of 200 mM phosphate buffer at pH of 7.0 with 1.000 mM trimethylsilypropanoic acid (TMSP) in
50% D2O was added to the supernatant as the internal NMR reference and lock solvent. For
NMR analysis, 550 μL of the sample was transferred to a clean 5 mm NMR tube (Wilmad Lab
Glass, USA).
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2.3.4

NMR Spectroscopy
The 1H NMR spectra were obtained at 600 MHz and at a temperature of 298 K on a 600

MHz Bruker Avance III cryoprobe equipped NMR spectrometer. A 1D-NOESY (noesypr1d)
pulse sequence was used to obtain the spectra. The pulse sequence used presaturation on the
water signal during 4 s relaxation delay (d1) and 50 ms mixing time (d8) to suppress the water
signal at 4.75 ppm (o1p). A total of 64 free induction decays (FIDs) were collected with a 20
ppm spectral width. The TMSP reference peak was used as an internal standard.
The TMSP peak for each spectrum was calibrated to 0 ppm and then peaks were
manually phased and baseline corrected. Compounds in the processed spectra were identified
and quantified using AMIX-Viewer v3.9.14 software (Bruker Biospin GmbH). Peaks were
identified by comparison to a library of pure, 3.000 mM standard compounds. This library
contained a total of 56 common metabolites and was created in-house. The library contained
chemical shift data and peak integrations for each compound, although some peaks in crowded
spectral regions were excluded from analysis. The output from AMIX was a listing of
concentrations for each of the 56 compounds at a given time point. Concentrations versus time
were collected to form a large data matrix for AC-treated, BC-treated, or untreated RPMI media,
and this matrix was then used for statistical analysis, described below.
2.3.5

BET and SEM Analysis
The Brunauer-Emmett-Teller (BET) analysis was used to measure the adsorption of

nitrogen gas on the surface area of BC and AC. BET surface areas, pore volumes, and averaged
pore diameters of BC and AC were examined using Micromeritics TriStar II Plus 3030 surface
area analyzer using a nitrogen adsorption isotherm at 77 K.
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Scanning electron microscopy (SEM) was used to determine BC and AC morphology.
Sample preparation for SEM was prepared as described above, however, reagent amounts and
volumes were scaled down for microscopy. 150 mg of BC or AC was added to 3 mL RPMI
media in a sterile 15 mL conical tube. This set of samples was placed in the shaker for 24 h with
no bacteria to characterize BC and AC morphologies in RPMI media alone. The 10 mL
overnight stock culture had a final O.D.600 of 0.732. 500 mg of BC or AC was added to 10 mL
RPMI media and then the overnight culture was equally divided into the three media types. The
starting O.D.600 value for each media was 0.224. The O.D.600 after 24 h of growing was 0.815 for
RPMI media, 0.668 for BC-treated media, and 0.375 for AC-treated media. Each sample was
vacuum filtered using a Buchner funnel. The samples were each placed into a sterile glass vial
and dried in the oven for three days at 67 °C. To analyze the samples on SEM, carbon tape was
placed onto a specimen holder, and the tape was gently coated with an even layer of BC or AC.
Excess particles were removed using compressed air. Once all samples were mounted onto the
specimen holder, the holder was placed under vacuum and coated with 20 nm of Pt in a sputter
coater. The surface morphologies of BC and AC were then examined by SEM using a JEOL
JSM-6500F FE-SEM (Institute for Imaging and Analytical Technologies (I2AT), Mississippi
State, MS) at 5 kV.
2.3.6

Statistical Analysis
Statistical analysis was conducted using MetaboAnalyst.37 The average metabolite

concentrations of three replicates for each sample was determined for each incubation time and
media type. MetaboAnalyst normalized the data with Pareto scaling, which is mean centered and
divided by the square root of the standard deviation of each variable. Pareto scaling was used to
reduce the influence of the intense peaks and emphasize the weaker peaks to interpret the
44

biological relevance.33 Once the data was normalized, two statistical methods used for data
analysis were multivariate analysis (PCA) and cluster analysis (heatmaps).
For PCA analysis, the data set was divided into principal components (PC) to identify the
statistical differences between the classes. The first component (PC1) was the linear combination
of the original predictor variables that captured the maximum variance in the data, whereas the
other components (second, third, fourth, etc.) were the linear combination that captured the
remaining variance in the data set and were orthogonal to the first component.38-39 A biplot was
used to identify metabolites that were significantly different between RPMI, BC, and AC
samples.40 The metabolites with the largest variance in metabolic profile were easily identified in
the biplot due to a larger vector magnitude that represented a large change in metabolic
concentration. Significant metabolites (p < 0.05) were determined using a two-sample t-test with
unequal variances. The significant metabolites identified were color coded as yellow in the biplot
compared to the other metabolites colored gray in the biplot.
A heatmap of normalized, relative concentrations was used to visualize the relationship
between two sets of data by using a color scale.41 The heatmap employed a hierarchical
clustering analysis of the metabolites that was based on Pearson’s correlation and Ward’s
linkage. Pearson’s correlation determined the linear correlation between the variables and
Ward’s linkage algorithm was based on the Euclidean distance that minimized the sum of the
squares of any two clusters.37,42-43 The heatmap used a color scale to represent the variance in
concentration for each metabolite in the sample.
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2.4
2.4.1

Results and Discussion
Initial Adsorption of Metabolic Compounds
The adsorptive properties of BC and AC make them ideal as soil additives in agriculture

because BC and AC enhance the soil’s physical and chemical properties by increasing the water
holding capacity, retaining nutrients, enhancing CEC, increasing surface area, and influencing
hydrophobicity.1,3,10,15 Variations in BC and AC feedstock and pyrolysis conditions produce
materials with varied adsorptive properties. This allows chars to be tailored to enhance specific
soil conditions. Varying the adsorptive properties of BC is an effective strategy for removing
specific chemicals in soil and water. Woody chars typically have a higher CEC, allowing them to
be used as a carbon sequester agent as well as a soil amendment.44-45 Woody BCs are typically
used to remove metals, pesticides, and pharmaceuticals from soil and water.44,46-48
Both organic and inorganic BC components influence adsorption.49 Chars that contain a
higher percentage of ash and low carbon content are not as energy efficient and are less useful
for adsorbing compounds.45 BC and AC containing a higher carbon content, usually found in
woody and plant materials, demonstrates an increased adsorption of water, metals, and
metabolites relative to chars containing a lower carbon content.45 High pyrolysis temperatures
effect the sorption of BC by increasing the surface area, microporosity, and hydrophobicity,
whereas the low pyrolysis temperatures removes inorganic and polar organic contaminants by
oxygen-containing functional groups, electrostatic attraction, and precipitation.46 In this study,
we used Ultra-Rinsed Black Owl Biochar, a commercially available soil amendment
manufactured from Douglas fir waste wood.
Both BC and AC adsorbed many metabolites when introduced into RPMI media (Fig.
2.1) including amino acids and D-glucose. Figure 2.1 represents a few of the metabolites that
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were adsorbed by BC and AC that are not part of the tricarboxylic acid (TCA) cycle. These
metabolites were selected based on PCA statistical analysis of their behavior in AC-treated vs.
BC-treated media. Five metabolites (L-cystine, L-isoleucine, L-leucine, L-lysine, and L-proline)
showed a decrease in concentration for both BC and AC. These five metabolites were adsorbed
more by AC than BC. The sixth metabolite (cis-4-hydroxy-L-proline) was only adsorbed by AC,
whereas BC had the same concentration as RPMI media. The three of the remaining four
metabolites (L-methionine, L-serine, and L-tyrosine) were adsorbed more by BC than AC. Lphenylalanine was completely adsorbed by both BC and AC. Overall, the addition of BC and AC
into the RPMI media introduced an environmental factor that altered the bacterial growth rate
(Fig. 2.2).
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Figure 2.1

Initial Metabolite Concentration in Media Immediately after Treatment with
Biochar or Activated Carbon.

The initial metabolite concentrations of (1) L-Cystine, (2) L-Isoleucine, (3) L-Leucine, (4) LLysine, (5) L-Proline, (6) Cis-4-hydoxy-L-proline, (7) L-Methionine, (8) L-Phenylalanine, (9) LSerine, and (10) L-Tyrosine in RPMI (control, solid black), BC (diagonally stripped, black and
white), and AC (dark gray) media 5 min after initial mixing. Error bars are the standard error of
the mean of three independently prepared samples. One-way ANOVA with Tukey’s HSD test
was used to identify the significant differences between RPMI and either BC- or AC-treated
media. A single asterisk (*) indicates that the RPMI concentration is significantly different from
both AC and BC media at a p-value < 0.05. A double asterisk (**) indicates a p-value < 0.005.
The difference shown between concentrations in AC- and BC-treated media were not statistically
significant for initial adsorption.
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2.4.2

E. coli Growth in RPMI vs Treated Media
E. coli was grown in RPMI media for the overnight stock culture up to 12 h and used as

the starting culture with an initial O.D.600 of 0.285. RPMI media was treated with BC and AC to
observe how their presence affected the bacterial growth rate. In unfiltered experiments, BC and
AC remained in RPMI media during bacterial growth. In filtered experiments, BC and AC were
filtered from RPMI media before bacterial growth. From the O.D.600, it was observed that E. coli
grew more readily in RPMI media with more abundant metabolites than treated RPMI media,
likely indicating the adsorption of nutrients by BC and AC influenced the bacterial growth rate
(Fig. 2.2). For the first 3 h, BC- and AC-treated media had a similar growth rate, whereas after 3
h E. coli adapted to BC-treated media and reached stationary phase for unfiltered AC-treated
media (Fig. 2.2 A.). The stationary phase for both RPMI and unfiltered BC-treated media was
reached around 6 h. The filtered BC- and AC-treated media showed similar results as unfiltered
media, where they had a slower growth rate than RPMI media. AC reached stationary phase
faster than BC (Fig. 2.2 B.). The main difference between the two growth curves was filtered
BC-treated media had a slightly slower growth rate than AC-treated media initially but reached
stationary phase around 9 h. The slower growth rate seen in BC and AC was from the adsorption
of metabolites that were needed for bacterial growth. For example, the starting concentration of
D-glucose decreased when BC and AC were introduced into RPMI media. Furthermore, Lasparagine and L-glutamine also had a significant decrease in concentration once BC and AC
were introduced into RPMI media.
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Figure 2.2

Growth Curves of E. coli in RPMI Media.

Growth curves of E. coli in (A) unfiltered and (B) filtered RPMI media (black dots with solid
black line), BC-treated RPMI media (opened black square with a dashed black line), and ACtreated RPMI media (black triangles with a dotted black line). In the filtered experiments, BC
and AC are removed before growth occurs. Error bars are the standard error of the mean of three
identically prepared samples.
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2.4.3

Bacterial Interaction with BC and AC Particles
After confirming the effects of AC and BC on bacterial growth, we investigated the

structural interaction of bacterial cells with BC and AC surfaces using scanning electron
microscopy (SEM). SEM was used to measure the surface morphology of BC and AC without
RPMI media, with RPMI media, and with E. coli in RPMI media. The surface of BC was
observed to be flat and smooth, while AC was porous and coarse (Fig. 2.3 and A.1), agreeing
with previous comparisons of AC and BC.34-35 SEM images of BC showed a morphology change
as RPMI and E. coli were introduced to the char, with the smoother microscopic texture of BC
making it easier to observe the attachment of material to the surface (Fig. 2.3 A. and. A.1). When
BC was introduced to RPMI media and E. coli cultures, there were small patches of adsorbed
metabolites and bacterial cells visible on the surface of the char (Fig. 2.3, B. and C.). After
treatment with bacteria, the biochar appeared to have numerous bacterial colonies (Fig. 2.3 C.),
and several of these colonies contained clusters of 3-4 1 μm sized cells. E. coli biofilms can take
up to several days to form,50 but Sugimoto, et al. observed similarly sized clusters during the
early formation of E. coli biofilms.51 This suggests that biofilms may form on the flat surfaces
present in biochar. The formation of biofilms are due to bacterial cells self-producing
extracellular polymeric matrix comprising of polysaccharides, proteins, lipids, and nucleic
acids.52 The extracellular polymeric matrix enhances bacterial surface to attach to the rich
oxygen functional group surface of BC and AC to further bacterial cell proliferation.52 The
hydrophobic surface of E. coli influenced the positively cell-adsorption and increase the amount
of metabolites bound to the negatively charged surface of BC and AC.53
On the other hand, the coarse surface of AC made it difficult to observe any adsorbed
metabolites or bacteria (Fig. 2.3, D.-F.). AC was observed to have a larger surface area than BC
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(Fig. 2.3), and overall adsorption of metabolites was found to be higher (Fig. 2.1). The absence
of bacterial clusters, however, suggests that biofilms will form much more slowly on the surface
of AC, if at all. The adsorption of metabolites on BC and AC introduced an environmental stress
to the media, where bacteria had to compete for nutrients (Fig. 2.2). It is possible that this stress
factor significantly altered the bacterial growth, making biofilm formation more likely on BC
surfaces than AC surfaces.
As previously noted above, the surface charge of BC and AC determine the adsorption of
metabolites and bacteria.52-53 The point of zero charge (PZC) for BC and AC was determined to
be 9.825 and 8.850 (Fig. A.2). The higher the PZC enhanced the capacity to adsorb positively
charged species by increasing the electrostatic interactions.53 The zeta potential of BC and AC
suspended in water was also determined to be -31.1  1.7 mV and -17.9  1.1 mV. Both PZC and
zeta potential identified that BC had a more negative charge on the surface than AC. The
negative surface of BC increase the metabolites and the likely hood of biofilm formation on BC
surface due to the increase in electrostatic interactions (Fig. 2.3 C.).
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Figure 2.3

SEM of Bacterial Interactions with Biochar and Activated Carbon.

(A) Douglas fir, Ultra-Rinsed Black Owl Biochar (BC), (B) BC in RPMI media, (C) BC in
RPMI media with E. coli, (D) Norit Activated Carbon (AC), (E) AC in RPMI media, and (F) AC
in RPMI media with E. coli. The surface morphologies were studied at 5 kV. The 20 μm scale in
(D) was used for all the other figures as well.
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The pore size of BC and AC can potentially modulate adhesion of bacteria to the
material. Previous studies have suggested a relationship between pore size and bacterial
adhesion. An overly large or small pore size will diminish adhesion due to pore curvature being
too small for the bacteria to adhere (large pore size) or due to physical exclusion from the pores
(small pore size).11 Brunauer, Emmett, and Teller (BET) analysis was used to estimate the
surface area and average pore size of BC and AC. This analysis does not quantify surface
curvature, but rather measures the surface areas of solids by physical adsorption of N2 gas
molecules.
BET analysis revealed that BC (14.3  0.4 Å) had a smaller average pore size than AC
(15.1  0.8 Å) (Table 2.1). The wet mass of BC before pyrolysis created steam pockets that
ruptured during the fast pyrolysis that increased the surface area.34-36,44,48 Moreover, AC has a
higher surface area then BC used in this study. These observations are consistent with the fact
that AC is able to adsorb more small compounds overall, suggesting that surface area and
adsorption capacity play the primary role in modulating bacterial growth following treatment
with BC or AC. Surface area and pore size may also play a secondary role in controlling
bacterial attachment, even though the BET pore sizes are much smaller than even a single
bacterial cell. This secondary role follows because the BET pore size will influence which cell
surface components of the E. coli outer membrane are able to interact with the BC or AC
surface. Additionally, it is known that selective adsorption of nutrients themselves are able to
assist in bacterial accumulation to a surface.54 Therefore, the surface characteristics of BC and
AC on a molecular scale can potentially have a larger-scale influence on bacterial colonization.
While it is difficult to correlate BET measurements with surface roughness,55 the BET surface
area approximately reflects the smoothness of the surface as visualized by SEM (Fig. 2.3 A.-C.).
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Thus, it is possible that pore size in BC is more conducive to binding E. coil cell surface
components. This would in turn make the smooth, flat surfaces of BC more easily able to
accommodate bacterial attachment and colonization.

Table 2.1

BET Particle Size Analysis.

Surface Area
Total Pore
Mean Pore
2
3
(SA) (m /g)
Volume (cm /g)
Size (Å)
Black Owl Biochar
419.7  53.3
0.17  0.03
14.3  0.4
Activated Carbon
603.9  64.4
0.33  0.09
15.1  0.8
Standard error of the mean of three independently prepared samples.

2.4.4

Metabolite Excretion and Adsorption During Bacterial Growth
To investigate the effect BC and AC have on glucose metabolism, we examined the

concentration dependence of several key compounds in glycolysis and the TCA cycle. The TCA
cycle is a good indicator of bacterial growth in the presence of external stressors, because it
represents the major pathways for energy flux in the cell.56-57 D-glucose is one of the main
carbon sources in RPMI media that was depleted and was shown to have an inverse-relationship
with bacterial growth (Fig. 2.2). The process of glycolysis rapidly converts D-glucose to
pyruvate in E. coli, and both compounds can be quantified using NMR (Fig. 2.4).23 D-glucose
was completely depleted in RPMI and BC-treated media (an indication of bacteria growth),
whereas the concentration of D-glucose in AC-treated media was only slightly reduced (minimal
bacteria growth). When D-glucose is depleted as part of the TCA cycle, the concentration of
byproducts, like acetate and pyruvate increase.
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Examination of the TCA cycle revealed several similarities and differences between cells
treated with AC or BC. For example, acetoin, lactate, and L-valine showed a decrease in
concentration for BC- and AC-treated media, whereas RPMI media had a higher concentration
than treated media for these compounds. In the TCA cycle, citrate concentrations in BC-treated
media behaved similarly to AC-treated media, whereas RPMI media increased in concentration
over the same time frame. L-glutamine, D-glucose, and L-asparagine decreased slowly in
concentration for BC-treated media and RPMI media, whereas AC-treated media concentrations
for these metabolites decreased faster. In the TCA cycle, 2-oxoglutarate for BC-treated media
had a similar rate compared to RPMI media. Fumarate, L-aspartate, L-glutamate, and acetate for
BC-treated media behaved differently compared to AC-treated and RPMI media. The patches of
adsorbed metabolites on the surface of BC and AC seen in the SEM images helped explain why
we observed a difference in concentrations for a few metabolites in RPMI media (Fig. 2.3 and
2.4).
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Figure 2.4

Tricarboxylic Acid (TCA) Cycle of E. coli.

The extracellular metabolite concentrations of E. coli in RPMI (blue), BC (green), and AC (red)
media, arranged with respect to common metabolic pathways. Error bars are the standard error of
the mean for three identically prepared samples.
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The concentration of the extracellular metabolites was also visualized using a clustered
heatmap (Fig. 2.5, A.3, and A.5 C.). A heatmap graphically represents the change in metabolite
concentrations versus time with a color scale being used to represent the row Z-score. This
heatmap covers the complete list of 56 metabolites used in this analysis, including the glycolysisrelated compounds already discussed.
In general, AC-treated media had very low concentrations for most of the metabolites in
comparison to BC-treated and RPMI media. AC adsorbed more metabolites than BC, as
evidenced from the first time point (0 h) before the cultures were inoculated. Interestingly,
adsorption profiles for AC and BC differ significantly, with compounds like L-isoleucine,
choline chloride, L-leucine, and 2-oxoglutarate adsorbing more strongly to AC. Over time,
however, the metabolic profiles for BC- and AC-treated media were seen to be similar when
compared to untreated RPMI media. For example, glycine and L-asparagine in BC- and ACtreated media had very similar trends in decreasing concentration compared to untreated RPMI
media, which decreased quickly in concentration.
Several compounds, including acetate, L-glutamate, L-proline, L-alanine, and pyruvate,
peaked in concentration in RPMI media at 6 h, then rapidly decreased as key metabolites,
including D-glucose (carbon source) and L-glutamine (nitrogen source), were utilized by E. coli
cells. Given that cells replicate more rapidly in RPMI media, this peak may reflect the point at
which the initial nutrients are depleted, and cells must adapt to a more competitive environment.
In AC- and BC-treated media, the overall nutrient concentrations are already reduced, and this
effect becomes less pronounced. It is weakly visible in BC-treated media, but such an effect is
not observed in AC-treated samples.
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The heatmap clusters into two general classes of compounds: those that increase in
concentration in RPMI media, and those that decrease over time. Smaller clusters reflect
differences in behavior of those compounds in AC- and BC-treated media. Across all three types
of media, the concentrations were generally observed to correlate, although several exceptions to
this were observed. The increasing concentration of fumarate in BC-treated media, already
discussed above, is one example of this. The increase of formate and ethanolamine in AC-treated
media at longer time points is another. For these two compounds the concentration remains
approximately constant in BC-treated media, and in RPMI the concentration is observed to
decrease. It is not clear why these compounds behave differently when treated with AC, but it
may reflect differences in adsorption over time for each type of treatment. Importantly, the
compounds do not appear to form smaller clusters based on simple chemical properties such as
charge and/or hydrophobicity: this suggests that the concentration dependence originates from
metabolic changes, and not simple adsorption or desorption to AC or BC surface. The
metabolites in the heatmap (Fig. 2.5) were arranged based on metabolic groups, such as amino
acids, vitamins, sugars, constituent bases, nucleosides, and organic compounds, to identify any
trends within the metabolic groups (Fig. A.3). However, there is no significant trends within the
metabolic groups, suggesting that the concentration dependence originates from the metabolic
changes and not based on simple chemical properties of AC or BC adsorption.
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Figure 2.5

Heatmap of Extracellular Metabolites in Unfiltered Media.

Heatmap of extracellular metabolites’ relative concentrations versus time in unfiltered media.
The row Z-score for each feature was used to color code the map: absent to low concentration
metabolites were colored blue and high concentration metabolites were colored red. Ward’s
linkage algorithm ranked the metabolites in a clustering tree. The red boxes were labeled as ACtreated media as time increases from 0 to 24 h going left to right. The green boxes were BCtreated media and the blue boxes were RPMI media. Data are the mean values of metabolite
concentrations of three replicates after being normalized using Pareto scaling.
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Analysis of the initial adsorption of metabolites revealed that both BC and AC depleted
some nutrients needed for bacterial growth. Overall, BC adsorbed a lower quantity of
metabolites than AC. The filtered and unfiltered media had similar characteristics in metabolite
adsorptions. PCA analysis had very similar results for unfiltered and filtered media, where BCtreated media had similar characteristics to AC-treated and RPMI media (Fig. 2.6 and A.5). The
heatmaps overall had similar metabolic profiles between filtered and unfiltered media (Fig. 2.5
and A.5). For unfiltered samples, the adsorbed metabolites can potentially be returned to the
media, leading to persistent differences through the growth cycle. However, filtration removes
AC or BC, and those samples permanently lose the initial concentration of adsorbed metabolites.
Since filtered and unfiltered samples both have similar profiles, the desorption and
resorption of metabolites to the surface during the experiment do not appear to alter the bacteria
growth significantly. Rather, it is the initial adsorption of metabolites to the char’s surface that
seems to most dramatically influence the bacterial growth rate. This is significant, as it suggests
that supplementing BC with several key nutrients may be an effective strategy for offsetting any
adverse effects in soil bacterial growth rates.
2.4.5

Statistical Analysis of Metabolites Present After Growth
The metabolic data were further analyzed using statistical analysis provided by

MetaboAnalyst suite.37 PCA was used to determine statistically meaningful differences between
three media types (score plot shown in Fig. 2.6 A. and A.5 A.). Removal of BC or AC by
filtration before inoculation made essentially no difference in the principal components (Fig. 2.6
A.). Both filtered and unfiltered growth showed a clear differentiation between RPMI and ACtreated media as determined by the ellipses representing 95% confidence intervals (Fig. 2.6 A.
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and A.5 A.). However, the behavior of BC-treated media showed similarities to both AC-treated
and RPMI media, demonstrated by its overlap on the scatter plot.
The first and second component for unfiltered and filtered media accounted for the
largest variation between the media. These two components combined account for 88.3% of the
variance in the data, with the first two components (PC1, PC2) accounting for 55.6% and 32.7%
of the variance, respectively. This observation that BC-treated media retains characteristics of
AC-treated media as well as untreated RPMI media is consistent with qualitative comparisons
previously noted above. Since AC adsorbs more metabolites than BC, AC can be viewed as a
more aggressive amendment, whereas BC retains some of the adsorptive capabilities of AC
while promoting conditions favorable for bacterial growth.
An examination of the scatter plot (and biplot) reveals that the early time points of BCtreated media cluster near RPMI media, whereas later time points cluster with AC-treated media.
After approximately 6 h, the data points corresponding to BC-treated media diverge from the
cluster of early timepoints on the scatter plot and trend toward the cluster of AC-treated media. It
is this multi-modal behavior that gives rise to a substantially larger confidence interval for BCtreated media (Fig. 2.6 A. and A.5 A.). Based on the loadings (Fig. 2.6 B. and A.5 B.), Dglucose, L-arginine, and acetate contribute significantly to the second principal component, and
the depletion of these compounds leads to the transition from one cluster to the other on the
biplot.
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Figure 2.6

Statistical Analysis of E. coli in Unfiltered RPMI Media.

(A) Principal component analysis (PCA) scores plot on E. coli growth in unfiltered media used to
identify statistical differences between each media type. The shaded oval represents the 95%
confidence limit for each media type (RPMI, blue circles; BC-treated media, green circles; ACtreated media, red circles). Time points for each hour are labeled, but points at half hour intervals
are not labeled for clarity. (B) Metabolites in the loading plot (left and lower axes) overlaid on
the PCA biplot (right and upper axes) for unfiltered media. Yellow dots represent the significant
metabolites (p < 0.05), i.e., those making the largest contribution to each principal component
(RPMI, blue squares; BC-treated media, green diamonds; AC-treated media, red triangles).
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The component loadings identify which metabolite concentration differences contribute
to PC1 and PC2 (Fig. 2.6 B. and A.5 B.).37 The metabolites with the largest variance in the
metabolic profile were identified and labeled as significant metabolites (yellow dots, Fig. 2.6 B.
and A.5 B.). The magnitude of the vectors for the significant metabolites quantifies the change in
the concentrations for each principal component. Therefore, the longer vectors represent a larger
change in metabolite concentrations and the shorter vectors represent a smaller change in
metabolite concentrations.
The largest contributor to the loading plots is the metabolites that deviates from the
clustered metabolites (Fig. 2.6 B., gray dots). This deviation could only be seen in Loading 1,
Loading 2, or both, where the metabolites will cluster based on their trend during the growth. As
observed in the TCA cycle (Fig. 2.4), D-Glucose decreased in concentration over time while
acetate increased in concentration resulting in these metabolites to be on opposite ends of
Loading 1 and Loading 2 (Fig. A.4). The largest contributors to the first loading were acetate, Larginine, isoamyl isovalerate, and D-glucose, whereas the second loading was dominated by
acetate, D-glucose and L-arginine. These data indicate that, following treatment with BC or AC,
significant differences are observed in the extracellular metabolite concentrations of these
compounds. BC and AC alter the media in complex ways, leading to significant differences in
several extracellular metabolite concentrations, and these changes cannot be explained by the
adsorption of simply one or two compounds. Moreover, some metabolite concentrations remain
unaffected or show little discriminatory power between samples (Fig. 2.6 B., grey circles). This
suggests that, treatment with AC and BC leaves many compounds unaffected during bacterial
growth.
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To summarize, based on our measurements, there were statistically significant differences
between RPMI and AC-treated media, whereas BC-treated media shared characteristics with
both RPMI and AC-treated media. This suggests that the favorable properties of BC, namely, its
ability to retain nutrients, may not adversely affect the bacterial life cycle in the way that other
adsorbents, such as AC, might. This is especially true at early time points, where extracellular
metabolite concentrations for BC-treated cells were observed to behave similarly to cells
growing in untreated media. Together, these results have implications for biochar when used as a
soil amendment. BC’s adsorption properties enhance soil fertility and structure, add needed
nutrients like carbon and nitrogen to the soil, and enhance soil microorganisms 4-7. Moreover, BC
influences crops to grow larger and faster because BC enhances the soil’s physical and chemical
properties by increasing pH, aeration, water holding capacity, and adding nutrients; BC also
adsorbs metabolites that alters bacterial growth.3,11,13
This study begins to explain these effects at the level of bacterial metabolome. Here, the
behavior of metabolites demonstrates that BC can effectively adsorb certain compounds, similar
to AC, while leaving others available for utilization by soil microbiota. It is this property that
allows BC to exhibit the favorable properties of RPMI media during the early time points when
bacteria are doubling rapidly. At the same time, BC is known to adsorb hydrophobic compounds
and retain nitrogenous fertilizers,11-13 making conditions favorable for plant growth. Combined,
these properties create conditions that favor growth of both crops and soil microbiota. While BC
can adsorb nutrients needed by microorganisms, as demonstrated by the initial depletion of Dglucose, oxoglutarate, and several other compounds, this effect appears to be minor compared to
AC, where aggressive adsorption of these compounds leads to poor bacterial growth.
Interestingly, the selective adsorption of metabolites could lead to conditions that favor one
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particular organism over another. While we have not explored the influence of BC on different
populations of microbes, this work strongly suggests that BC can alter metabolite concentrations
to favor one particular organism over another. For example, the addition of BC or AC mainly
had a positive effect on the abundance of mycorrhizal fungi, but in some cases BC or AC limited
the nutrients and the mycorrhizal fungi was hindered.58 It was also observed that the relationship
between mycorrhizal fungi and BC sequesters carbon (mitigating climate change) to restore the
ecosystem.58
In summary, as a soil amendment, biochar’s metabolic effects on soil microbiota have
been largely uninvestigated. Here, we explored how biochar can alter the metabolomic profile of
E. coli. There were significant differences between RPMI and AC-treated media, whereas BCtreated media shared characteristics with both RPMI and AC-treated media. This suggests a
mechanism whereby BC can adsorb nutrients without adversely affecting soil microbiota. While
cell culture does not represent soil conditions, the experiments capture the essential properties of
adsorption by BC and AC, evidenced by the concentration of metabolites. Efforts are underway
to understand how BC influences the populations of soil biota.
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CHAPTER III
A NOVEL TOOL FOR METABOLOMICS USING NMR SPECTROSCOPY: DIPSI-PSYCHE
TOCSY FOR ANALYSIS OF COMPLEX MIXTURES
3.1

Abstract
Metabolomics studies the gene environment interactions by measuring the time-

dependent concentration of molecules (or metabolites) that compose the products of a network of
metabolic pathways. A 1D proton NMR spectrum, typically used for identifying and quantifying
metabolite concentrations, provides key insight in the biological sample metabolism. The
samples are complex mixtures with molecules that have high spectral overlap in the 1D NMR
spectrum. We implemented a novel NMR technique that affords better molecular resolution in
these complex mixtures. Here, we apply this technique to a model sample containing 20 known
metabolites, as well as a sample of extracellular metabolites from Streptococcus pneumoniae (S.
pneumoniae). Our approach employs a pure-shift TOCSY that yields uncoupled peaks in the
indirect acquisition dimension. The DIPSI-PSYCHE TOCSY pulse sequence is suitable for
aqueous samples, has enhanced peak resolution, and better separation compared to the 1D proton
and conventional TOCSY spectra. This increased resolution comes at the expense of signal to
noise ratio compared to a conventional TOCSY; however, increased signal averaging can
overcome this drawback. The improved resolution allows better separation of spin systems,
especially for D-glucose and L-arginine. These two metabolites are of high biological interest,
where L-arginine metabolism has been implicated in streptococcal biofilm formation. Both D72

glucose and L-arginine have a triplet at 3.25 ppm in the 1D spectrum, which makes identification
and quantification challenging. However, in a pure shift TOCSY spectrum these spin systems are
well resolved. Our approach suggests that pure shift TOCSY NMR experiment is extremely
beneficial to investigate the metabolic profiles between strains of S. pneumoniae.
3.2

Introduction
Metabolomics is the chemical footprint of all small biological molecules that accurately

describe the organism’s current physiological states.1-5 This footprint addresses a wide range of
scientific questions in biological, medical, environmental, agricultural, and nutritional research.13,5

For example, metabolomics has identified biomarkers or drug targets under a variety of

physiological conditions, which have led to methods to prevent, diagnose, and manage diseases.6
Mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy have been widely
used to efficiently and accurately identify both known and unknown metabolites in their complex
environment to understand how organisms respond to environment interactions.2,4-5,7-8
The most common technique used for metabolomic analysis is MS due to the high
throughput, high sensitivity, and soft ionization.9 MS large range analysis detects up to thousands
of metabolites in one complex sample, as well as using a wide range of instruments (ESI, FAB,
GC, and LC) that can be coupled with each other to detect various types of metabolites such as
polar, nonpolar, and volatile.6,9 Metabolomics MS analyses can be done under both positive
(+ve) and negative (-ve) ionization modes under the scan range of m/z 50-1000 to maximize the
metabolites covered in the complex biological sample.9 However, MS analysis has many
disadvantages for metabolomic analysis. For example, MS usually requires an extra solvent
separation step to extract the wanted metabolites, requires expensive internal standards for
absolute quantitation, less reproducible, and destructive to the samples.6
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Even though MS is the most common technique for analysis, NMR studies have
contributed extremely useful information to the multidisciplinary metabolomics fields.6
Recently, new approaches to NMR metabolomics methods have been applied to improve
quantitation, resolution, and range of metabolites.6 NMR methods do not require any lengthy
separation steps for metabolite extractions and is non-destructive to the samples. 4,6,10 On the
other hand, NMR methods are highly quantitative, highly reproducible, and complementary to
MS methods.4,6,10 NMR also requires a single internal or external reference, such as DSS or
TMSP, for absolute quantitation. 4,6,10 A combination of NMR techniques, including isotope
labeling, allow unknown structure determination and enhance the limit of detection (LOD).
However, NMR detects fewer metabolites compared to MS, is less sensitive with an LOD of 1
μM, and is limited by spectral resolution.3,6
In this work, we describe a novel NMR technique to investigate Streptococcus
pneumoniae (S. pneumoniae), a fermentative microaerophilic anaerobe bacterium, to identify the
metabolic profile differences between two strains, T4R (wild type) and Δ1434-8 (lacks an operon
that is highly upregulated in the response to zinc-chelation).11-12 The basic metabolic
characteristic of S. pneumoniae is represented by the increase of extracellular lactic acid due to
the high rate of glycolysis.11 In this study, we compare a conventional 1D proton (1H) NMR,
conventional 2D TOCSY NMR, and 2D DIPSI-PSYCHE TOCSY NMR techniques as applied to
the metabolite system. The 1H NMR data are usually sufficient and is reasonably resolved;13
however, in complex samples the spectral overlap of various metabolites makes it challenging to
identify and quantify these signals.5 The TOCSY NMR experiment increases the resolution of
peaks by adding the second 1H dimension.14-17 Metabolites in the crowded region of the spectrum
become easier to identify due to the correlated protons creating cross-peaks in the 2nd
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dimension.4,8,10,14,16,18 To simplify the conventional TOCSY spectra, a pure shift (DIPSIPSYCHE) NMR pulse program can be applied to the TOCSY spectra to enhance the resolution
of the conventional TOCSY.4,7,14-15,18-24 By applying a chirp in the 2nd dimension of the TOCSY
sequence, multiplet peaks are simplified to singlet peaks by removing the scalar couplings (J) of
the protons.7,14-15,18-25 This chirp applies low flip angle frequency swept pulses in the presence of
field gradient to select a small proportion of spins and suppress responses from passive spins.21
This simplification makes it easier to identify the metabolite patterns and reduces spectral
overlap in the 2nd dimension.
We demonstrate how these three NMR techniques can be applied to a model metabolic
mixture, as well as samples from the extracellular medium of S. pneumoniae to gain insight on
how the wild type (T4R) and knock-out gene (Δ1434-8) are metabolically different. The
extracellular metabolites provide insight in the metabolic footprint for S. pneumoniae.13 In the
metabolic mixture, D-glucose and L-arginine were of interest since both compounds had a triplet
at 3.25 ppm in the 1H NMR. With the enhanced resolution by adding a second dimension, the
TOCSY and DIPSI-PYSCHE TOCSY separated the spin systems to easily identify the
contributor to the triplet at 3.25 ppm. D-glucose and L-arginine are of high biological interest
because D-glucose is a great carbon source for the bacteria to survive and L-arginine metabolism
has been identified in streptococcal biofilm formation.26 Our results provide insight on how a
novel NMR technique can be applied to metabolomics studies and enhance the identification and
quantification of metabolites in complex samples.
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3.3
3.3.1

Materials and Methods
Sample Preparation
Twenty molecules that model metabolites were prepared containing various

concentrations from 0 to 0.5 mM of 4-aminobenzoate, adenosine, biotin, cis-4-hydroxy-Lproline, D-glucose, DL-4-hydroxyllactate, glycerol, isoamyl isovalerate, L-arginine, L-aspartate,
L-glutamate, L-histidine, L-lysine, L-phenylalanine, L-serine, L-tryptophan, L-valine,
myoinositol, sucrose, and uridine. These metabolites were selected for this study due to the large
spectral overlap seen in the 1D 1H NMR spectra. 200 μL of 200 mM phosphate buffer at pH of
7.0 with 1.000 mM TMSP) in 50% D2O was added to 400 μL of the supernatant as the internal
NMR reference and lock solvent. For NMR analysis, 550 μL of the sample was transferred to a
clean 5 mm NMR tube (Wilmad Lab Glass, USA).
S. pneumoniae strains TIGR4 unencapsulated mutant (T4R) and T4R lacking SP14341438 (Δ1434-8) were grown in C+Y medium. T4R and Δ1434-8 strains were grown to O.D.600
of 0.2, 0.35, and 0.5. One mL samples of the cultures were removed and centrifuged at 16,000 x
g for 5 min. The sampling was performed in triplicate. The supernatants were sterile filtered
using 0.22 μm filter. 200 μL of reference buffer and lock solvent, previously described for
standards, was added to 400 μL of the supernatant.
3.3.2

NMR Experiments and Data Processing
The 1H, conventional TOCSY, and DIPSI-PSYCHE TOCSY NMR spectra were obtained

at a temperature of 298 K on a 600 MHz Bruker Avance III cryoprobe equipped NMR
spectrometer. A 1D-NOESY (noesypr1d) pulse sequence was used to obtain 1H NMR spectrum
with a total of 64 free induction decays (FIDs) collected with a 20 ppm spectral width.27-28
Presaturation was applied at 4.75 ppm (o1p) during the 4 s relaxation delay (d1) and 50 ms
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mixing time (d8) to suppress the water signal.28 A conventional 2D-TOCSY (mlev) pulse
sequence was used to obtain 2D 1H-1H spectrum. Each FID collected used 2 scans and the
indirect dimension was sampled for 85 ms for a total of 1024 complex points. The pulse
sequence incorporated a broadband homonuclear decoupling using a flip back pulse in the t1
dimension. During the 80 ms TOCSY mixing time, a zero-quantum filter was applied, and water
flip back pulses were used to optimize water suppression.29 A modified 2D-TOCSY
(dipsi2gpphzsprespe_psyche) pulse sequence was used to obtain 2D 1H-1H NMR spectrum. Each
FID collected used 2 scans and the indirect dimension was sampled for 85 ms for a total of 1024
complex points. The pulse sequence incorporated broadband homonuclear decoupling using
PSYCHE chirp in the t1 dimension.15,19-20 Similar to the conventional TOCSY, a zero-quantum
filter was applied during the 80 ms TOCSY mixing time, as well as a water flip back pulses used
to optimize water suppression.29 Additional water suppression and solvent filtering on the
TOCSY spectrum were performed with in-house scripts for NMRPipe.30
The TMSP peak (internal standard) for each spectrum was calibrated to 0 ppm and
manually processed. A metabolic library, containing a total of 56 common metabolites, was
created in-house using AMIX-Viewer v3.9.14 software (Bruker Biospin GmbH) to identify and
quantify the compounds in the processed spectra.28 Chemical shift and peak integration data for
each compound were added to the library, although there were some exclusion of peaks in the
crowded spectral regions from the analysis. The output file from AMIX listed the concentration
for each compound for each sample.
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3.4
3.4.1

Results and Discussion
Identifying and Quantifying a 20 Metabolite Mixture
The spectral width for a standard 1H NMR spectrum is typically sufficient for the

identification and quantification of the metabolic peaks. However, many of the metabolites have
chemical shifts between 3 and 5 ppm leading to overlapping signals in the spectrum (Fig. 3.1
A.).4,7,31 A model sample composed of 20 chemicals that have significant spectral overlap in a 1H
NMR spectrum similar to metabolites were investigated to enhance the identification and
quantification for that compound in a complex sample. These chemicals were selected based on
their NMR chemical shifts to separate a spectrum with overlapping peaks. Some model
metabolites, including D-glucose and glycerol, had a majority of their peaks within the 3 to 5
ppm region of the spectrum making it challenging to identify the peak pattern for the
compounds. This spectral overlap limits how many metabolites can be studied in a 1H NMR
spectrum at one time. For 1H NMR, the in-house library containing 56 compounds that are
known metabolites is the limit for analysis without introducing significant spectral overlap
during analysis.
Figure 3.1 A. represents the standard and summation (gray line) of four compounds in the
library that slightly overlap with each other in the spectrum between 3 and 5 ppm. The
summation of the four metabolites is a good representation of a typical 1D 1H NMR spectra of
complex samples. The summation spectra represents how challenging it is to identify all the
peaks in the spectrum when a few peaks slightly overlap. Also, D-glucose (blue) and L-arginine
(green) have a triplet peak at 3.25 ppm making it challenging to identify the triplet at 3.25 ppm in
the summation spectrum, metabolite mixture, or complex bacterial sample (Fig. 3.1 A.). Adding
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the second dimension to the NMR analysis reduces the likelihood of peaks overlapping by
spreading the spin resonance out in the indirect direction creating correlated cross-peaks.8,32
A 2D TOCSY spectrum is an alternative to the 1H NMR spectrum as the TOCSY yields a
complete spin-spin connectivity information to reconstruct molecular spin systems.4,16-17,32-33
TOCSY simplifies the analysis of metabolites in the crowded region of the 1H NMR spectrum. In
a TOCSY spectrum, the diagonal peak would correspond to a 1D 1H NMR spectrum with
correlated proton spins creating a cross-peak on either side of the diagonal (Fig. 3.1 B. and
C.).8,15,20,33 Just like the 1H NMR spectrum, each metabolite will have a unique cross-peak
pattern making it easier to identify the metabolites creating that peak. Going back to the example
having a triplet at 3.25 ppm, D-glucose (blue) should have two sets of cross-peaks on either side
of the diagonal; whereas L-arginine (green) would have one set of cross-peaks (Fig. 3.1 B. and
C.). In the conventional TOCSY, scalar couplings (J) between protons convey structural
information but reduce the resolution of the spectra with the splitting of signal creates multiplet
cross-peaks.4,8,15,20,25 However, pure shift experiments (PSYCHE) are added to pulse sequences
to enhance sensitivity, spectral purity, and tolerance of strong coupling by suppressing the
multiplet into a singlet.7,15,18,20,22,34 The DIPSI-PSYCHE TOCSY measured the spin coupling of
the metabolites in the direct dimension; however, DIPSI-PSYCHE converted the multiplet peaks
into a singlet in the indirect dimension to simplify the cross-peak signals making it easy to pick
up the metabolite chemical shift patterns (Fig. 3.1 C.). The only difference between Figure 3.1 B.
and C. is the indirect dimension line shape for each metabolite peak.
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Figure 3.1

NMR Profiles of 4 Metabolites Identified in the 20 Metabolite Mixture.

A.) 1D 1H NMR, B.) 2D Conventional TOCSY NMR, and C.) DIPSI-PSYCHE TOCSY NMR
of D-glucose (blue), glycerol (red), L-arginine (green), L-tryptophan (purple), and the
summation of all 1D spectra (gray).
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The limit of detection (LOD) for the 20 metabolite mixture was investigated to determine
the lower limit of quantification for the DIPSI-PSYCHE TOCSY NMR metabolic library. The
metabolite mixtures with varying metabolite concentrations (0-0.5 mM) were used to determine
the LOD using DIPSI-PSYCHE TOCSY NMR. The concentration for each metabolite was
determined using the in-house library in AMIX. The LOD was calculated using the following
equation:

𝐿𝑂𝐷 =

3.3 𝜎
𝑆

(3.1)

where σ is the standard deviation of the y-intercepts of the regression lines and S is the slope of
the calibration curve.35 The majority of the 20 metabolites in the mixture had a LOD smaller than
0.05 mM, where only 8 metabolites in the mixture had a LOD higher than 0.05 mM (Table 3.1).
The LOD confirmed that adding the DIPSI-PSYCHE to the conventional TOCSY NMR pulse
program simplified the identification and quantification of metabolites compared to the 1H NMR
and the conventional TOCSY. A typical 1H NMR metabolite spectrum has a LOD of ~1 μM,6
but the LOD for each metabolite is heavily influenced by peak overlapping as well as metabolite
abundance in the sample.
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Table 3.1

Limit of Detection (LOD) for the 20 Metabolite Mixture.

Metabolites
4-Aminobenzoate
Adenosine
Biotin
Cis-4-hydroxy-L-proline
D-Glucose
DL-4-hydroxyllactate
Glycerol
Isoamyl Isovalerate
L-Arginine
L-Aspartate
L-Histidine
L-Glutamate
L-Lysine
L-Phenylalanine
L-Serine
L-Tryptophan
L-Valine
Myoinositol
Sucrose
Uridine

3.4.2

Standard Deviation of
y-intercepts of the
regression lines (σ)
0.002
0.009
0.019
0.014
0.012
0.017
0.024
0.021
0.002
0.009
0.004
0.014
0.011
0.008
0.002
0.004
0.010
0.025
0.009
0.005

Slope of
Calibration
Curve (S)
0.619
0.932
0.991
0.771
0.973
0.810
0.997
0.869
0.657
0.846
0.925
0.871
0.670
0.933
0.547
0.933
0.953
0.894
1.103
0.873

LOD (mM)
𝟑. 𝟑 𝝈
=
𝑺
0.012
0.033
0.065
0.058
0.040
0.070
0.081
0.079
0.012
0.036
0.013
0.051
0.055
0.027
0.015
0.015
0.033
0.092
0.027
0.020

Identifying and Quantifying Extracellular Metabolites of S. pneumoniae
DIPSI-PSYCHE TOCSY was applied to investigate the extracellular metabolites of S.

pneumoniae (Fig. 3.2). The 1H NMR spectrum for S. pneumoniae (Fig. 3.2 A.) had a lot of peak
overlap as compared to the 20 metabolite mixture (Fig. 3.1 A.). This spectral overlap observed in
S. pneumoniae grown in C+Y media was due to other metabolites excreted, not listed in the inhouse library, in the media as the bacteria grew over the allotted time course (Fig. 3.2 A). The
2D TOCSY NMR experiment made it easier to identify the metabolic peak patterns due to the
cross-peaks correlated to the diagonal; however, the spectrum was still crowded due to the peaks
splitting by the J-coupling (Fig. 3.2 B.). With the high spectral overlap in the diagonal, the cross82

peaks slightly overlapped other metabolites’ cross-peaks due to the J-couplings resulting in
multiplet peaks in both dimensions (Fig. 3.2 B.) When the DIPSI-PSYCHE was applied to the
TOCSY pulse sequence, the extracellular metabolites of S. pneumoniae were easy to identify due
to the simplification of multiplets to singlets, reducing the peak shape, in the indirect dimension
(Fig. 3.2C. and 3.3). This simplification made it easier to identify the cross-peak metabolic
pattern and reduce the spectral overlap observed in both the 1H NMR and conventional TOCSY
(Fig. 3.2).
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Figure 3.2

NMR Profiles of T4R S. pneumoniae.

A.) 1D 1H NMR, B.) 2D Conventional TOCSY NMR, and C.) DIPSI-PSYCHE TOCSY NMR
of T4R S. pneumoniae.
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Even though the addition of DIPSI-PSYCHE to the TOCSY pulse sequence made it
clearer to identify the metabolic patterns in the complex media, the signal-to-noise (S/N) ratio
loss was a concern. A small section of the correlated cross-peaks (Fig. 3.3, zoomed in) compares
the S/N ratio between the conventional TOCSY (red) and DIPSI-PSYCHE TOCSY (blue). For
the conventional TOCSY, the average S/N ratio of the multiplets was used to compare to the
singlet DIPSI-TOCSY S/N ratio (Table 3.2). The S/N loss was calculated by taking the
conventional TOSCY S/N divided by the DIPSI-PSYCHE S/N. The average S/N loss for the
small section of correlated cross-peaks (Fig. 3.3) for T4R was calculated to be 1.73. This average
S/N loss for T4R showed that the simplification of the conventional TOCSY using DIPSIPSYCHE did not significantly reduce the S/N ratio in the DIPSI-PSYCHE TOCSY spectrum. It
would be of great concern if the average S/N loss for T4R was larger than 2 because the S/N
ratio would be reduced by more than half. A significant S/N loss in the spectrum would influence
the resolution of the spectrum making it difficult to identify the metabolites that are typically
lower in abundance, e.g. L-tryptophan, in the media supernatant.
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Table 3.2

S/N Loss Comparison Between TOCSY and DIPSI-PSYCHE TOCSY for T4R S.
pneumoniae.

DIPSIPSYCHE
S/N Loss
S/N Loss
Peak Number
TOCSY
(mlev/dipsi)
(dipsi/mlev)
(dipsi) S/N
1
161
91
1.77
0.57
2
134
109
1.23
0.81
3
65
79
0.82
1.22
4
210
142
1.48
0.68
5
148
103
1.44
0.70
6
58
45
1.29
0.78
7
77
38
2.03
0.49
8
133
70
1.90
0.53
9
334
119
2.81
0.36
10
139
73
1.90
0.53
11
178
98
1.82
0.55
12
221
172
1.28
0.78
13
178
106
1.68
0.60
14
195
110
1.77
0.56
15
148
132
1.12
0.89
16
95
84
1.13
0.89
17
196
94
2.09
0.48
18
237
118
2.01
0.50
19
85
30
2.83
0.35
20
72
33
2.17
0.46
Average S/N Loss
1.73
0.64
Peaks selected for this analysis are the ones shown in Figure 3.3. For the conventional TOCSY
multiplet peaks were averaged to easily compare the value to the DIPSI-PSYCHE TOCSY
singlet. The average S/N loss were calculated based on these 20 peaks.
Conventional
TOCSY
(mlev) S/N
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Figure 3.3

S/N Ratio Comparison for TOCSY and DIPSI-PSYCHE TOCSY NMR for T4R S.
pneumoniae.

T4R S. pneumoniae signal-to-noise (S/N) loss comparing conventional TOCSY (red) and DIPSIPSYCHE TOCSY (blue). The average S/N loss for T4R using this set of cross-peaks was 1.73.
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The extracellular metabolites of S. pneumoniae were identified using both 1D and 2D
NMR experiments by comparing the bacterial sample spectrum to the in-house, 56 metabolites
library in AMIX.28 As shown in Figure 3.1 with the various colors representing a standard
metabolite, AMIX identified the metabolic patterns based on the chemical shift (1D and 2D
NMR), as well as the cross-peak patterns in the 2D NMR spectra (Fig. 3.1 and 3.2). The DIPSIPSYCHE TOCSY spectra made it clearer to identify the metabolites based on their correlated
cross-peaks. However, AMIX only used the 1H NMR to quantify the metabolites. The LOD for
the 20 metabolite mixture (Table 3.1) confirms that adding the second dimension to the NMR
analysis simplified the identification and accurately determined the concentration for each
metabolite. These extracellular metabolites of S. pneumoniae were investigated to gain insight on
the metabolic profiles of two different strains. Based on the model metabolic library, the
metabolites of interest were related to the aerobic tricarboxylic acid cycle (TCA)28 and did not
observe major differences between the two strains.12 However, under certain conditions, such as
aerobiosis, sugar limitation, or presence of other carbohydrates, the glucose causes a metabolic
shift from homolactic (lactate production) to mixed-acid fermentation (ethanol, acetate, and
formate).11 An observed increase in the by-product concentrations for either strain in the
extracellular media would provide insight into the metabolic shift from homolactic (lactate byproduct formation) to mixed-acid fermentation (acetate and formate by-product formation).12
However, with the size limit of the in-house metabolic library, it is difficult to fully investigate
this metabolic shift from homolactic to mixed-acid fermentation. Also, it is difficult to fully
investigate S. pneumoniae metabolic pathway to gain insight on the biofilm formation due to the
size limits of the in-house metabolic library.
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Once the metabolites have been identified and quantified for S. pneumoniae T4R (wild
type) and Δ1434-8 (lacks an operon) based on the TCA metabolites, the metabolite concentration
for each strain versus O.D.600 was graphed to visualize the metabolic profiles for each strain. In
this study, the extracellular metabolites of S. pneumoniae monitored fall into two main classes:
compounds that rapidly increase as the O.D.600 increases (secreted) or compounds that decrease
(uptake) over time.11 The metabolites that rapidly increase in concentration as the O.D.600
increases include lactate, L-serine, L-lysine, and L-arginine; whereas the compounds that
decrease in concentration over time are D-glucose and pyruvate (Fig. 3.4). For the majority of
the metabolites, T4R and Δ1434-8 had very similar concentration rates. For example, L-proline
(Fig. 3.4), D-glucose, and L-threonine had very similar concentrations and slightly decreased
over time between the two strains. However, there were a few metabolites that had significant
differences in concentration over time (Fig. 3.4). For many of these amino acids, Δ1434-8 had a
higher concentration than T4R suggesting that more of these amino acids are being secreted into
the C+Y media by Δ1434-8 than T4R (Fig. 3.4). On the other hand, T4R had a higher
concentration of pyruvate than Δ1434-8 suggesting that more of the pyruvate is upregulated by
Δ1434-8 (Fig. 3.4) due to the metabolic shift between homolactic (lactate production) to a
mixed-acid fermentation (acetate and formate production).11 In addition, the higher concentration
of L-arginine in the extracellular media suggests that the arginine metabolism activity is low for
Δ1434-8 as compared to T4R.36 The low metabolic activity yields a lower baseline ATP level
resulting in the formation of S. pneumoniae biofilms.36
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Figure 3.4

Metabolic Profiles of S. pneumoniae T4R and Δ1434-8.

S. pneumoniae T4R (wild type, blue) and Δ1434-8 (knockout, red) metabolic profiles for Lserine, L-cysteine, L-leucine, pyruvate, L-isoleucine, L-Lysine, L-proline, and L-arginine as
O.D.600 increases over time. Error bars are the standard error of the mean of three independently
prepared samples.

90

3.5

Conclusion
The present study applied a novel NMR technique to investigate the metabolic profiles of

a standard 20 metabolite mixture and S. pneumoniae extracellular metabolites. A DIPSIPSYCHE pure shift chirp was added to the 2D TOCSY pulse sequence to simplify the spectrum
in the indirect dimension.15,20,37 The DIPSI-PSYCHE TOCSY spectrum had enhanced peak
resolution and better peak separation compared to the 1H NMR and conventional TOCSY. The
pure shift chirp averaged the multiplet peaks in the indirect dimension to a singlet peak to
simplify the spectrum for identification of metabolic patterns in a complex sample. The increased
resolution is better for identification of complex mixtures at the expense of the S/N ratio. In our
study, we observed that around half the S/N ratio was lost with the addition of DIPSI-PSYCHE
with relatively intense cross-peaks compared to the conventional TOCSY. The improved
resolution with the 2D NMR techniques allowed for better separation of spin systems, especially
for D-glucose and L-arginine that have been implicated in streptococcal biofilm formation. A
triplet at 3.25 ppm in a 1D spectrum of a complex mixture could correspond to either D-glucose
or L-arginine. With this spectral overlap, it is challenging to identify and quantify each
metabolite of interest if the metabolic pattern for each compound is obstructed by other
compounds. However, in a pure shift TOCSY spectra these spin systems are well resolved with
the simplification of multiplets in the indirect dimension making identification of the metabolic
pattern easier. Our approach suggests that the pure shift TOCSY NMR is extremely beneficial to
investigate the metabolic profiles between two strains of S. pneumoniae: T4R (wild type) and
Δ1434-8 (lacks an operon). In this study, we observed that the C+Y media was crowded in the
1

H NMR spectrum making it extremely challenging to identify the metabolites in those regions.

The DIPSI-PSYCHE TOCSY NMR spectrum was easier to identify the metabolites in the
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crowded regions due to the correlated protons in the cross-peaks. We also identified that the two
strains of S. pneumoniae had very similar metabolic profiles, except for a few amino acids (Larginine, L-cysteine, and L-lysine) and other products (acetate, lactate, and pyruvate). From a
previous study, a change in these extracellular metabolites suggests that there is a shift from
homolactic (lactate production) to a mixed-acid fermentation (acetate and formate production).11
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CHAPTER IV
INVESTIGATING THE KINETICS OF PROTEIN COMPETITION ONTO NANOPARTICLE
SURFACES USING TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE
4.1

Abstract
Gold nanoparticles (AuNPs) have numerous biological applications, including drug

delivery, chemotherapy, biosensing, and bioimaging. When exposed to biological fluids, AuNPs
will interact with proteins in solution, and these proteins will compete to bind to the AuNP
surface. It remains impossible to predict the outcome of competitive binding to AuNPs, but this
knowledge could potentially aid scientists hoping to target nanoparticles to specific cells in the
body. NMR has been used extensively to study interactions between biological molecules in
solution. Here, we employ a 2D 1H-15N HSQC NMR method to study how proteins compete to
bind to AuNP surfaces, exploring aspects of thermodynamic and kinetic control. Specifically, we
used a 1H-15N HSQC technique to quantify AuNP binding for various protein mixtures. These
protein mixtures contain various concentrations of GB3 and Ubiquitin, two small model proteins,
or Amidase (AM) and R2ab, two larger protein domains of the autolysin protein from
Staphylococcus epidermidis implicated in biofilm formation. The mixtures were sampled at 1.25
h intervals to investigate the protein competition, enabling quantification of AuNP binding over
time. Our results suggest that competition between GB3 and Ubq is not strictly kinetically
controlled due to the imperfect packing interactions on the AuNP surface during competition.
However, the competition between AM and R2ab is kinetically controlled as our results were
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very similar to the theoretical values. Together, our results suggest a mechanism by which
nanoparticle surface character may change over time and influence protein binding, and this may
be an important consideration in the design of nanoparticle-based therapeutics.
4.2

Introduction
Nanoparticles, especially gold (AuNP), are of great interest in numerous applications

including optical, electrical, and medical properties due to their simple synthesis process, welldefined surface chemistry, and non-toxicity.1-5 In the past decade, AuNPs have been used in
numerous medical applications including drug and gene delivery, chemotherapy, biosensing, and
bioimaging.1-3,6 When AuNPs are exposed to biological fluids, proteins in solution will compete
to bind to AuNP surface. This protein competition will spontaneously adsorb to the AuNP
surface resulting in the formation of a stable protein corona.1,3,7-11 However, this protein corona
will change over time depending on the type of tissues, protein concentrations, protein binding
affinity, and other physical factors including size and charge.10-11 The protein corona is classified
into two distinct regions of the nanoparticle known as the soft and hard regions of the corona.
The soft corona is the outer-most layer of the AuNP surface that consists of loosely bound
proteins associated with the surface, where the proteins are in equilibrium with the local
environment.12-14 The hard corona is the inner-most layer that consists of tightly bound proteins
associated with the NP surface and for most NPs, this region consists of irreversible bound
proteins.7,12 Being able to quantify the competitive binding of protein mixtures will give insight
on how and why proteins adsorb onto the AuNP surface.
In previous studies, GB3 and ubiquitin (Ubq) were used as model proteins to investigate
the importance of the electrostatic interactions of protein competition on the AuNP surfaces.11,15
Both proteins are highly characterized,16-17 easily isotopically labeled for NMR studies, and
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specifically used to model the protein-nanoparticles (P-NP) interactions.15,18-20 The 1D filtered
NMR-based approach identified that the competition on the AuNP surface favors the protein
with the highest net charge, as well as identifying that the protein corona changes with varying
pH over time.15 The observed change in the protein corona composition highlights how crucial
the electrostatic interactions are to protein-nanoparticle (P-NP) interactions.15 This GB3-Ubq
model approach for protein competition on AuNP surfaces can be applied to more interesting
protein mixtures, such as biofilm forming proteins, to gain insight into how these proteins
interact and compete on the AuNP surfaces.
Biofilms are bacterial cells that are in close association with surfaces and interfaces that
cause multicellular aggregates.21-23 These biofilms produce an extracellular matrix, typically
comprised of polysaccharides, proteins, and nucleic acids, which create an envelope that adds
resistance to antibiotics and host immune responses. The formation of these biofilms occur in
two phases: 1) rapid bacteria attachment to the surface or 2) prolong accumulation phase that
involves the cell proliferation and intercellular adhesion.22-23 The biofilm forming proteins of
interest for this study belong to the Staphylococcus epidermidis (S. epidermidis) autolysin E
(AtlE).22,24-25 S. epidermidis is a serious nosocomial pathogen that frequently causes infections
associated with implanted foreign bodies including intravascular catheters, cerebrospinal fluid
shunts, prosthetic heart valves, and cardiac pacemakers.22-23,26 These infections are caused by the
colonization of multilayered cell clusters on the polymer surfaces.22-23
AtlE, a complex multidomain structure expressed on the surface of S. epidermidis, has
been shown to bind to bare polystyrene, as well as fibrinogen, fibronectin, and vitronectin coated
surfaces giving rise to the primary interactions for biofilm formation on the surfaces.22,27-29 The
AtlE protein has been identified to contain an amidase and glucosaminidase domain.22,30 Here,
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we will focus on the amidase domain, specifically the amidase (AM) catalytic and R2ab domains
due to their role in binding to polystyrene and fibrinogen, fibronectin, and vitronectin coated
surfaces.22,27-29 AM is a 24 kDa, zinc metalloenzyme that binds peptidoglycan and catalyzes
amide bond cleavage between N‐acetyl muramic acid and L‐alanine of peptidoglycan.30
Whereas, R2ab is a 17 kDa protein that contains two small half open β-barrel repeats separated
by a short linker.30 Investigating how these biofilm forming proteins interact onto the highly
characterized AuNP surface will provide the framework in understanding the competition and
electrostatic of biofilm forming proteins onto various NP surfaces, such as polystyrene, silica NP
(SiNP), and titanium NP (TiNP).
Here, we investigate how the electrostatic interactions influence the affinity and
competition between proteins onto the AuNP surface. As noted earlier, the driving force for the
pH-dependent binding, or protein adsorption, to AuNP was the electrostatic interactions.11,15
GB3 and Ubq competing for the AuNP surface was used as a model since this interaction is well
characterized, both proteins are very similar in size and shape, and serves as a useful platform for
understanding how biofilm forming proteins interact with nanoparticle surfaces. To gain insight
on the binding affinities of AtlE, AM and R2ab proteins were used to investigate the competition
of two proteins from the same domain. For this study, all proteins were isotopically labeled (15N)
to utilize a 2D 1H-15N heteronuclear single-quantum coherence (HSQC) NMR technique to
quantify the protein competition on AuNP surfaces.5,19,31 The electrostatic interactions play a key
role in the formation of the protein corona when protein competes for the AuNP surface.
However, it was observed that during the competition between GB3 and Ubq resulted in an
imperfect packing interaction on the AuNP surface. This imperfect packing interaction resulted
in a sigmoidal shape for Ubq binding concentrations as the presence of Ubq decreased and GB3
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increased in solution. Whereas, the biofilm forming protein mixture competition did not favor
any specific protein in the mixture as observed by AM and R2ab behaving similarly to the
theoretical value and the simple kinetic model applied to describe the kinetic behavior of the
competition.
4.3
4.3.1

Materials and Methods
Protein Synthesis and Purification
All proteins were isotopically labeled using 15N-ammonium chloride in M9 media. GB3

and Ubq protein were expressed and purified according to methods described previously.15,19
AM and R2ab protein were expressed and purified according to the methods described below.
R2ab (pET15b plasmid) was transformed into E. coli BL21(star) DE3 competent cells
(Invetrogen) for expression and purification. R2ab is flagged at the N-terminus by three residues
(MGS) followed by a histidine tag residues and thrombin cleavage site. After cleavage, R2ab
contains 152 amino acids. The transformed cells were grown overnight shaking at 200 rpm and
37°C in 50 mL M9 media. The overnight starter culture was used to inoculate the larger 1 L M9
minimal media with an initial optical density at 600 nm (O.D.600) of 0.05. The larger culture was
returned to the shaker shaking at 200 rpm and 37°C until the O.D.600 reached 0.7. Once the
desired O.D.600 was reached, the cells were induced with 1 mM isopropyl β-D1thiogalactopyronoside (IPTG) and harvested after 6 h. The cells were pelleted by centrifugation
for 30 min at 8000 x g and resuspended in lysis buffer (150 mM NaCl, 20 mM HEPES pH 7.5,
and 20 mM Imidazole). 1 mg/mL lysosome was added to the cells and rocked in an ice bath for
30 min. The cells were then sonicated using a Branson Sonicator at 45% power level for 2
minutes on and 1 minute off (3x). The sonicated lysate was centrifuged at 18,000 x g for 4 min at
4°C before Fast Performance Liquid Chromatography (FPLC) purification. The R2ab lysate was
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purified using a pre-equilibrated 5 mL nickel His Trap FF columns (GE Life Sciences). The
bound protein was eluted using a 60 mL linear gradient with the elution buffer containing 800
mM imidazole. The uncleaved protein was quantified and thrombin was added to the solution
and dialyzed overnight in the wash buffer. Thrombin was removed by adding 0.5 mL of
benzamidine sepharose beads (GE Life Sciences) and the solution was centrifuged. The
supernatant was purified using a pre-equilibrated 5 mL nickel His Trap FF column to remove the
cleavage tag. The purified protein was run through the pre-equilibrated 26/600 Superdex 75 Pg
Gel Filtration Column (50 mL NaCl, 20 mM NaPi). The purified R2ab was concentrated up to
500 μM.
Similarly, Amidase (pET15b plasmid) was transformed into E. coli BL21(star) DE3
competent cells (Invetrogen) for expression and purification. AM was expressed following the
same protocol as described for R2ab, except the expression was done at 25 °C after the addition
of IPTG. The cells were pelleted by centrifugation and resuspended in lysis buffer (50 mM NaPi,
pH 7.4, 300 mM NaCl and 10 mM imidazole). The AM cells were prepared similarly as
described for R2ab before the cells were ready for the first FPLC purification step. The AM
lysate was purified using a pre-equilibrated 5 mL nickel His Trap FF columns. The bound
protein was washed with 10 column volumes (CV) of resuspension buffer and 15 CV wash
buffer (50 mM NaPi, pH 7.4, 300 mM NaCl, and 25 mM imidazole) before AM was eluted using
an elution buffer (50 mM NaPi, pH 7.4, 300 mM NaCl, and 400 mM imidazole). AM was further
purified following the final R2ab purification steps from thrombin cleavage to the second 5 mL
nickel His Trap FF column to the Gel Filtration Column. The purified AM was concentrated up
to 500 μM.
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4.3.2

Protein Mixtures with Gold Nanoparticles
A single protein (20 μM) solution was prepared in 20 mM phosphate buffer at pH 7.0,

unless noted otherwise, with 10% D2O as the lock solvent. To quantify how much protein was
bound to the surface of AuNP, 20 mM 15N Urea was used as an external standard for the NMR
analysis. 15 nm citrate-stabilized AuNPs were synthesized as previously reported.15,19 The 20
μM protein solution was mixed with 20, 40, 60, and 80 nM AuNP solution and incubated for an
hour before recording the NMR spectra.
Solutions of two protein (total protein concentration of 50 μM), containing GB3-Ubq or
AM-R2ab, were prepared similarly as previously described for a single protein, except for the
protein concentration ranged from 0 to 50 μM. For example, the dilution series was 0, 15, 20, 25,
30, 35, and 50 μM GB3 and 50, 35, 30, 25, 20, 15, and 0 μM Ubq. The protein mixture was
mixed with 80 nM AuNP solution and incubated for an hour before recording the NMR spectra.
For the biofilm forming protein mixture (AM and R2ab), the dilution series was set-up similar to
GB3 and Ubq, except 60 nM AuNP were used instead of 80 nM AuNP.
4.3.3

NMR Analysis
1

H-15N HSQC NMR spectra were collected on a 600 MHz Bruker Avance III cryoprobe-

equipped instrument at 298 K as described previously.15,19 An indirect acquisition time of 300 ms
was used (512 complex points) for the AuNP titrations and protein competition. The total
experiment time for each spectrum was 1 h and 21 min. A signal decrease in the presences of
AuNPs is quantifiably related to the amount of adsorbed protein to AuNP surface.
1

H-15N HSQC spectra were processed using an in-house script convert and NMRPipe.32

Chemical shift assignments for GB3 and Ubq were obtained from previous studies (Fig. 4.1
A.).15,19,33-34 Similarly, AM and R2ab chemical shifts were assigned (Fig. 4.1 B.) [manuscripts in
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preparation]. The assignments used for GB3 in this study were Y3, N8, G9, T17, V21, D22,
G38, D47, K50, and E56. The assignments used for Ubq in this study were K6, T12, V17, D21,
K29, Q31, Q49, S57, L67, and H68. The assignments used for AM in this study were K307,
R335, E338, T344, G358, T370, A385, T466, T477, and R487. The assignments used for R2ab
in this study were L699, N704, A712, Y722, I732, D767 G809, N834, S837, and G838.
4.4
4.4.1

Results and Discussion
NMR Based Quantification: 1D vs. 2D Experiments
Previously, 1D NMR titrations were used to quantify the binding capacity of protein (P)

onto 15 nm gold nanoparticles (AuNP), as well as monitor the kinetics between two different
proteins competing for the AuNP surface.15,18-20 The predicted binding capacity is based on the
radius of gyration (RG) calculated from the protein structure and the radius of the NP (RNP) to
determine the maximum adsorption capacity (Nmax) (Equation 4.1).18-19 Whereas the measured
binding capacity for each protein is determined using the 1D or 2D NMR techniques to measure
the bound protein concentration plotted against the various AuNP concentrations. The predicted
binding capacity for GB3 and Ubq at pH 7.0 were 199 and 155 molecules per NP (Table 4.1).1819

The measured binding capacity from the 1D NMR experiment were comparable to the

predicted values (Table 4.1).
𝑁𝑚𝑎𝑥 = 4(

𝑅𝑁𝑃 2
)
𝑅𝐺

(4.1)

In the kinetic studies, isotopically labeled GB3 (13C) and Ubq (15N) were used to monitor
the competition and binding onto AuNP surfaces. The 1D NMR spectra for 15N labeled residues
will have a chemical shift range from 6 to 11 ppm representing the protein backbone amide
proton region, whereas 13C labeled residues will have a chemical shift range of 0 to 4 ppm
representing the protein backbone aliphatic proton region.15,19-20 It is observed that as the AuNP
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concentration increases, the peak intensities decrease; however, the peak shape is not altered or
shifted with the addition of AuNP.15,19-20 The spectra were quantified by scaling the peaks to the
internal standard of DSS to calculate the bound protein concentration (μM).15,19-20 To monitor
more than one protein interacting with the AuNP surface using 1D NMR, each protein has to
have a different isotope label for quantification.20 For example, when monitoring the kinetic rates
of two protein competing on the AuNP surface, 13C GB3 and 15N Ubq were used to monitor how
the aliphatic (GB3) and amide (Ubq) region changed in the presence of AuNP.15,20 This approach
is great if only two proteins are of interest due to the fast analysis (about 7.5 minutes per sample)
to monitor the kinetics or competition of these two proteins on the AuNP surface. However, it
becomes complicated when 3 or more proteins are of interest because a new isotope will need to
be introduced per protein of interest.
In this study, we were interested in using only one isotope (15N) to label a protein mixture
and apply a 2D NMR technique to monitor the protein competition (Fig. 4.1 A. and B.). Since
the isotope of choice was 15N, we are monitoring the backbone amide region as previously
mentioned above in the 1D NMR titrations discussion. With the addition of the second
dimension to the analysis, it is easier to identify and monitor the protein’s residues that are
interacting with the NP surface. Each residue has a specific chemical shift pattern (CSP)
allowing the spectrum peaks to be assigned for each protein.18-20,33-34 To quantify the peak
intensities, an external standard of 15N Urea was used to calculate the bound protein (μM) on the
AuNP surface. Urea was selected because the CSP was 5.68 ppm and does not overlap with any
of the protein amide chemical shifts.
We first investigated 15N GB3 and 15N Ubq using 2D HSQC to monitor the individual
proteins interacting with 15 nm AuNP (Fig. 4.1 A.). The predicted binding capacity was
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determined to be 199 (GB3) and 155 (Ubq) molecules per NP (Table 4.1).15,18-19 A linear
behavior was observed for GB3 and Ubq when the bound concentration (μM) versus AuNP
concentration (nM) were graphed suggesting that the NPs are saturated with the protein (Fig. 4.1
C.).15,18-20 Once the binding capacity was determined for each protein using the HSQC method,
the values were compared to the 1D NMR values (Table 4.1). For GB3 and Ubq, these values
were very similar to the previously reported 1D NMR values.15,18-19 This suggests that the 2D
HSQC method did not add any artifacts or line broadening effects to our analysis. For each
protein interacting with 80 nM AuNP were 14.4 (GB3) and 12.6 (Ubq) μM bound to the NP
surface. These measured values were used in the kinetic model for the theoretical values of
Protein A (N0A, GB3) and Protein B (N0B, Ubq).
Once it was determined how the protein behaved individually on the AuNP surface using
the 2D NMR approach, the proteins were mixed to monitor the competition of proteins onto the
AuNP surface. Ten residues were selected for analysis based on the residues that were well
resolved and had no spectral overlap (these residues are listed above in the Section 4.3.3) (Fig.
4.1 A.). These residues, for each protein, behave very similarly in the presence and absence of
AuNP, where the signal intensity is strong and there is no observed peak line broadening in the
presence of AuNP.
Table 4.1

Protein-AuNP Binding Capacities.

Binding Capacities
Protein
Predicted
1D NMR Values 2D NMR Values
GB3
199 18-19
177 18-19
174
18-19
Ubq
155
156 18-19
144
Amidase (AM)
85
93
R2ab
71
68
78
Predicted values were calculated based on the radius of gyration (RG) calculated from the protein
structure and the radius of the nanoparticles (equation 4 18-19).
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Figure 4.1

Protein Binding Capacities onto AuNP Surfaces.

Backbone amide 1H-15N heteronuclear single-quantum coherence (HSQC) experiment used to
quantify proteins isotopically labeled the same in solution. (A) 25 μM 15N-labeled GB3 and 25
μM 15N-labeled Ubq mixed with 80 nM AuNP and (B) 25 μM 15N-labeled AM and 25 μM 15Nlabeled R2ab mixed with 60 nM AuNP. The peak intensity perturbation measured for the equally
mixed protein mixtures in the absence of AuNP (blue spectra) and presence of AuNP (red
spectra). (C) The binding capacity for each protein is determined using the HSQC experiment by
plotting the protein bound concentration versus various AuNP concentration. 20 μM of each
protein was mixed with 0, 20, 40, 60, and 80 nM AuNP to identify how many molecules of
protein is bound to the NP surface. The observed concentrations for GB3 (blue diamonds), Ubq
(red triangles), AM (blue squares), and R2ab (red circles) are plotted against their expected
values for a monolayer of protein on NP surface (color coded lines for each protein listed
previously).
106

4.4.2

Protein Competition: Competitive Modeling
In previous studies, it is well established that once the nanoparticle enters the biological

system, a protein corona will form containing proteins that have a higher affinity for the
nanoparticle surface.1-3,7,9-10,20,35 However, little is known about the kinetics and thermodynamics
of this phenomena. Understanding how protein compete on the nanoparticle surface to create this
protein corona will enhance scientist’s knowledge in surface modification for drug targeting,
biosensors, and preventing biofilm formation on surfaces. In this model, we used two model
proteins (GB3 and Ubq) that are highly characterized using both 1D and 2D NMR techniques to
explore the kinetics and thermodynamics of the protein corona formation during protein
competition.
The binding capacity of GB3 (Fig. 4.1 C., blue) and Ubq (Fig. 4.1 C., red) [also
represented in Table 4.1] has been previously reported,15,18-19 as well as the competition kinetics
between GB3 and Ubq onto 15 nm AuNP surface.15 If both proteins were equally mixed (50:50
mixture), it would be expected that their AuNP adsorption behavior are similar due to their
similar shape and size (GB3 6.2 kDa and Ubq 8.6 kDa).15 However, if one protein interacted
more favorably, strongly to the surface, this protein would have a quantifiably larger binding
capacity than the other.15 Figure 4.2 A. is a schematic representing the competition between two
proteins onto the AuNP surface. Protein A (blue, GB3 – pdb 2OED) and Protein B (red, Ubq –
pdb 1UBQ) can both interact in the soft corona, the outer-most layer of the nanoparticle shell
where the binding is in equilibrium with the surrounding environment.7,12,14 The k1 rate for both
proteins must be greater than the k-1 rate since we observe binding (k2) to the AuNP. The hard
corona, the inner-most layer that consists of tightly bound proteins associated with the NP
surface,12-14 where the binding interaction is occurring and is an irreversible reaction (k2) once
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the protein binds to the citrate-coated AuNP surface. Once the NP binding sites in the hard
corona are full, the remaining protein reaches equilibrium in the soft corona and no more protein
can interact with the NP surface. This result identifies the k2 rate for the hard corona reaction to
be the rate limiting step.
The kinetics of the competition were modeled to observe the predicted behavior of two
proteins competing on the AuNP surface when the protein fraction varied from 0-1 Protein A
(blue) and the reverse ratio (1-0) for Protein B (red). Following the schematic in Figure 4.2 A.,
the kinetic reaction rates (k1, k-1, and k2) were changed to monitor how the proteins would behave
in a kinetically controlled reaction (Eq. B.1 – B.7). In most cases, the modeled data (solid line)
behaved similarly to the theoretical value (dashed line) with a few exceptions that deviated
significantly from the theoretical values (Fig. 4.2 B.).15 These deviations from the theoretical
values were observed when the binding ratio (k1/k1 or k1A/k1B), how quickly protein A and B
reach equilibrium in the soft corona (k1 and k-1), and the hardening rate(k2/k2 or k2A/k2B), how
quickly protein A and B form a monolayer on the AuNP surface in the hard corona (k2), change
over time (Fig. 4.2 B.). For example, if the binding ratio and hardening rate is low (upper left
graph), Protein B (red) is highly favored to bind to the AuNP than Protein A (blue) (Fig. 4.2 B.).
Following the diagonal in the 5x5 matrix graph to the lower right graph, it is observed that as the
binding ratio and hardening rate increase, the model gets closer to the theoretical values and
eventually Protein A is highly favored to bind to the AuNP surface (Fig. 4.2 B.). However, one
should note, if the model data falls below the theoretical value the protein is not favored to bind
with the AuNP surface, whereas if the model data falls above the theoretical value the protein is
highly favored to bind to the AuNP surface. Figure 4.2 B. supports this trend, no matter the
kinetic rates, if the sample is low in Protein A and high in Protein B, Protein B is highly favored
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to adsorb to the NP surface. If the sample is low in Protein B and high in Protein A, Protein A is
highly favored to adsorb to the NP surface.
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Figure 4.2

Protein Competition Model onto AuNP Surfaces.

(A) A simply schematic diagram of two proteins kinetically competing onto the AuNP surface.
Protein A (GB3, pdb 2OED) and Protein B (Ubq, pdb 1UBQ) are in the free environment
competing for the surface resulting a two-step reaction (k1 and k-1). The first initial contact with
the AuNP surface is the soft corona, or the outermost layer of the AuNP. Once the soft corona
and free environment reach equilibrium, in a forward reaction (k2), the proteins will form a
monolayer in the hard corona, or the innermost layer of the AuNP where the binding occurs. (B)
A 5x5 graph that represents how kinetics influence the shape of the modeled data. Each graph is
a representation of a series of matrices that have varying kinetic rates. Moving left and right in
the figure, represents how increasing the binding ratio, how quickly the proteins reach
equilibrium, influences the shape of the model data – either curved away from or very close to
the theoretical value. Moving up and down in the figure, represents how increasing the hardening
rate, how quickly a monolayer on the surface forms, also influences the shape of the model data.
As observed in the graphs, if one protein is above the theoretical line the other protein is below
the theoretical and will eventually approach the theoretical line.
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If this competition is kinetically controlled, it is easily suggested that the adsorption
behavior for Protein A and B are very similar and any deviations from the theoretical value is
due to the reaction rates and amount of protein present in the samples (Fig. 4.2 B.). The higher
concentration protein is highly favored to bind to the surface; whereas the lower concentration
protein is less favored to bind to the surface because the modeled data was below the theoretical
value. However, this phenomenon was not observed in the experimental competition of GB3 and
Ubq competing for the AuNP surface (Fig. 4.3). The data deviates from the theoretical value
significantly, as well as a sigmoidal shape for Ubq (Protein B in Fig. 4.2) is observed (Fig. 4.3).
This deviation suggests that this competition is experiencing a phenomenon that cannot be
explained using a simple kinetic model, where the only observed interaction is the proteins with
the AuNP surface. As observed in Figure 4.2 B., the graphs from the simple kinetic model
showed that although the reaction rates, binding ratio, and hardening rate changed did not create
a sigmoidal shape for Protein B (red lines). It is believed that the sigmoidal shape observed in the
experimental data is from the imperfect packing interactions onto the AuNP surface. As Ubq
takes up more sites on the NP surface, GB3 deforms to interact with the AuNP surface. When
more Protein A is present, the NP interaction is significantly reduced resulting in a lower binding
of both Protein A and B, whereas when no Protein A is present, the imperfect packing interaction
does not occur resulting in a normal behavior of Protein B. When Protein A is low, Protein B
dominates the interaction since it is kinetically faster and favorable to interact with the AuNP
surface.
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Figure 4.3

Model Proteins, GB3 and Ubq, Competition onto AuNP Surface.

GB3 [blue] and Ubq [red] competition onto the AuNP Surface (80 nM). The protein bound (µM)
vs. fraction of GB3 (%) determines the behavior of the competition. There is a total of 7 points
per solid line that represents the fraction of GB3 (%) used in each mixture - 0, 30, 40, 50, 60, 70,
and 100 % fraction of GB3. The blue and red dashed lines represent the theoretical value
(binding capacity). For each protein interacting with 80 nM AuNP were 14.4 (GB3) and 12.6
(Ubq) μM bound to the NP surface. The error bars represent the 95% confidence interval (CI) –
95% CI = standard error of the mean * Z-value. This Z-value can be found in a table for CI; the
Z-value for 95% CI is 1.96.
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4.4.3

Biofilm Formation Protein: Competition on the AuNP Surface
Biofilms are bacterial cells that produce an extracellular matrix, typically comprised of

polysaccharides, proteins, and nucleic acids, that are in close association with surfaces and
interfaces that cause multicellular aggregates that are resistant to antibiotics and host immune
responses.21-23 S. epidermidis AtlE biofilm proteins are of great interest because S. epidermidis
AtlE are identified as surface-associated proteins and frequently cause serious infections
associated with implanted foreign bodies including prosthetic heart valves and cardiac
pacemakers.22-26 AtlE contains a complex multidomain structure (Fig. 4.4), amidase and
glycosaminidase domain, expressed on the surface of S. epidermidis.22,30 Previously, it was
observed that the amidase domain interacts with the polystyrene surface through hydrophobic
interactions.22 The amidase domain contains the amidase catalytic domain, R1a, R1b, R2a and
R2b (Fig. 4.4). 22,27-29 It was also observed that the AM-R1ab-R2ab construct interact with the
membrane-bound lipoteichoic acid (LTA) and acts as a receptor for the AtlE in the septum
(cross-wall) region.30 However, the repeats (R1ab and R2ab) preferentially bind to LTA and
restrict the mobility of AM to bind to peptidoglycan (PGN) reducing the synthesis and
degradation of the bacterial cell wall.30 The AtlE repeats (R1ab and R2ab) are known to be the
cell wall anchoring units since they preferentially bind to the LTA.30 Investigating how these
biofilm proteins interact on the AuNP surfaces will provide the framework in understanding the
competition and electrostatic of biofilms onto various NP surfaces. This work could provide
some insight on which part of the domains is binding with various NP surfaces. Current
information on which part of the amidase domain is interacting with polystyrene and
biomolecular compounds such as PGN, LTA, fibronectin, fibrinogen, and vitronectin is
limited.22,30
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Figure 4.4

Structural Features and Topology of S. epidermidis AtlE Biofilm Forming
Proteins.

The two domains that comprise AtlE are highlighted at the top: Amidase and Glucosaminidase.
The Amidase domain contains the amidase catalytic domain and three half-open β-barrel R2ab
proteins. In this study, the amidase catalytic domain (AM – pdb 3LAT) and R2ab (pdb 4EPC)
are the biofilm proteins of interest. The red arrows indicate the sites of posttranslational
cleavage.
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As discussed earlier (Fig. 4.2), if both proteins were equally mixed, one would expect
that their AuNP adsorption behavior would deviate from the theoretical value slightly due to
their differences in shape and size. AM is predicted to have a slightly higher affinity to the AuNP
surface because AM is globular and less rigid than R2ab (Table 4.1). However, when both
proteins compete on the AuNP surface, they behave very similarly to the theoretical value
(dashed lines, Fig. 4.5). For each protein interacting with 60 nM AuNP was 5.08 (AM) and 4.42
(R2ab) μM bound to the NP surface. Since both proteins behave similarly to the theoretical
values, the competition between AM and R2ab is strictly kinetically controlled. The 5x5 matrix
graph (Fig. 4.2 B.) shows a few scenarios where the kinetic rates resulted in a similar behavior to
the theoretical values. Even though Figure 4.2 B. data represents GB3-Ubq interactions, where
the binding capacity (N0A and N0B) are set to GB3 and Ubq values, a similar design using AM
and R2ab binding capacity could be done to show how the kinetics rates will vary the shape of
the model data as the binding ratio and the hardening rates vary. Pinpointing the actual kinetic
rates using the MATLAB kinetic model (Fig. 4.2 B.) for AM-R2ab competition is challenging
and not beneficial due to the numerous input values resulting in similar graphs.
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Figure 4.5

Biofilm Forming Proteins, AM and R2ab, Competition onto AuNP Surface.

Amidase (AM) [blue] and R2ab [red] competition onto the AuNP Surface (60 nM). The protein
bound (µM) vs. fraction of AM (%) determines the behavior of the competition. There is a total
of 7 points per solid line that represents the fraction of AM (%) used in each mixture. These
points are 0, 30, 40, 50, 60, 70, and 100 % fraction of AM. The blue and red dashed lines
represent the theoretical value (binding capacity). For each protein interacting with 60 nM AuNP
were 5.08 (AM) and 4.42 (R2ab) μM bound to the NP surface. The error bars represent the 95%
confidence interval (CI) – 95% CI = standard error of the mean * Z-value. This Z-value can be
found in a table for CI; the Z-value for 95% CI is 1.96.
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The AM-R2ab competition did not behave similarly to GB3-Ubq competition. One could
predict that the phenomenon observed between GB3-Ubq was due to their similar shape
(globular and mainly β sheets) and small size (a difference of 2 kDa). This phenomenon allows
GB3 and Ubq to interact with each other, or imperfectly pack, in the soft corona and deform its
structure before hardening onto the AuNP surface. Whereas, AM and R2ab have unique
structures and size (a difference of 7 kDa) from each other (Fig. 4.4). AM is very globular and
contains central β sheet at core surrounded by mostly of α helixes; whereas R2ab is a two halfopen β barrel domain that is very rigid. The differences in structure between AM and R2ab could
explain why the two proteins when competing for the AuNP surface behave differently than GB3
and Ubq. AM and R2ab competition onto the AuNP behavior is very similarly to the theoretical
value due to the curvature and limited binding sites on the 15 nm AuNP surface to form a protein
monolayer. Examining the hydrodynamic diameter for each protein, protein mixture, and AuNP
using dynamic light scattering (DLS) confirmed a monolayer was formed on the surface of the
AuNP (Fig. B.1 and B.2). The hydrodynamic diameter for each protein mixture and AuNP were
two times the protein hydrodynamic diameter plus AuNP hydrodynamic diameter (2*H.D.Protein
+ H.D.AuNP). If protein-AuNP hydrodynamic diameter was significantly larger than the predicted
value then a multilayered protein corona formed on the NP surface. For GB3 and Ubq
competition on the AuNP, the hydrodynamic diameter for GB3-, Ubq-, and GB3-Ubq-AuNP
were 20 nm and the majority of the contributions to the diameter was the 17 nm AuNP (Table
4.2). For AM and R2ab competition on the AuNP, the hydrodynamic diameter for AM-, R2ab-,
and AM-R2ab-AuNP were around 27 nm and the majority of the contributions to the diameter
was the 17 nm AuNP (Table 4.2).
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Table 4.2

Dynamic Light Scattering of Protein-AuNP Conjugates.

Hydrodynamic
Hydrodynamic
Sample
Diameter (nm)
Diameter (nm)
GB3
AM
1.083  0.014
5.303  0.009
Ubq
R2ab
1.22  0.03
5.81  0.05
GB3-Ubq
AM-R2ab
1.16  0.04
5.35  0.06
15 nm AuNP
18.13  0.19
GB3-AuNP
AM-AuNP
20.7  0.3
31.0  1.3
Ubq-AuNP
R2ab-AuNP
20.9  0.2
27.9  1.5
GB3-Ubq-AuNP
AM-R2ab-AuNP
20.45  0.15
31.04  1.05
Hydrodynamic diameter observed by DLS. Uncertainties are the standard error of the mean from
three independently prepared samples.
Sample

4.5

Conclusion
In summary, a 2D HSQC approach was utilized to quantify the protein competition on

AuNP surfaces by using a single isotope to label a protein mixture. The added second
dimensions for 15N chemical shifts allow for good peak separation for each protein backbone
residues. A modeled protein mixture containing GB3 and Ubq were used since they are well
characterized and the binding capacity for each protein on AuNP surface has been previously
determined.15,18-19 In a kinetically controlled competition, if Protein A is low then Protein B is
highly favored to bind to the surface and vice versa if Protein B is low. Altering the binding ratio
and hardening rates in the kinetic model will yield in deviations from the theoretical binding
value for Protein A and B. However, this simple kinetic model cannot explain the competition
and interaction between GB3 and Ubq. This competition resulted in a unique phenomenon where
imperfect packing and protein interactions on the AuNP surface yields a sigmoidal shape for Ubq
(Protein B). However, the biofilm forming proteins of S. epidermidis AtlE (AM and R2ab)
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behaved differently than the competition between GB3 and Ubq. AM-R2ab competition was
kinetically controlled, where the experimental values behaved similarly to the theoretical values.
4.6
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APPENDIX A
SUPPORTING INFORMATION FOR EFFECT OF BIOCHAR ON MICROBIAL GROWTH:
A METABOLOMICS AND BACTERIOLOGICAL
INVESTIGATION IN E. coli
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Reprinted with permission from Hill, R.A.; Hunt, J.; Sanders, E.; Tran, M.; Burk, G.A.;
Mlsna, T.E.; and Fitzkee, N.C. Effect of Biochar on Microbial Growth: A Metabolomics and
Bacteriological Investigation in E. coli. Environmental Science and Technology 2019, 53 (5),
2635-2646. Copyright © 2019 American Chemical Society.
A.1
A.1.1

Supporting Materials and Methods
Media Treatment Preparation for Bacterial Growth
An additional set of experiments were performed to test BC adsorption of metabolites.

For these experiments, 0.001% (0.3 mg), 0.1% (3 mg), 1% (30 mg), and 10% (300 mg) of
Douglas fir, Ultra-Rinsed Black Owl Biochar (BC) or Norit Activated Carbon (AC) were
weighed out and placed in 15 mL sterile conical tubes. 3 mL of a metabolite mixture was
measured into each tube and placed in the floor shaker at 200 rpm at 25.0 °C for 24 hours. This
allowed ample time for BC and AC to adsorb metabolites from the sample in the absence of
bacterial growth. During this time, no significant growth was observed based on O.D.
measurements. After 24 hours of shaking, the media was filtered through a 25 mm
polyethersulfone (PES), 0.2 μm sterile syringe filter and 400 μL of the supernatant was
transferred to another clean, sterile microcentrifuge tube. 200 μL of 200 mM phosphate buffer at
pH of 7.0 with 1.000 mM trimethylsilypropanoic acid (TMSP) in 50% D2O was added to the
supernatant as the NMR reference and lock solvent. For NMR analysis, the same procedure
follows as described in the main text.
As the mass of BC and AC increased, the adsorption of metabolites from the mixture
increased. 10% of BC or AC was selected for the filter media because we observed a larger
difference in metabolite adsorption to the surface than the lower percent by weight samples.
Once the 10% of BC or AC was introduced to unfiltered media, the media became very thick,
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making it difficult to monitor the growth of E. coli in the media. So, 5% of BC or AC added to
the media was used for the unfiltered media. The 5% of BC or AC adsorbed enough metabolites
from the media to observe a difference in the metabolic profile of E. coli.
A.1.2

Point of Zero Charge of BC and AC
Point of zero charge (PZC) of BC and AC were determined using 0.01 M NaCl solution

with pH values ranging from 2 to 12. The pH values were adjusted using either 0.1 M NaOH or
0.1 M HCl solutions. 1 mL of 0.01 M NaCl solution was added to 50 mg of BC or AC in a clean,
sterile microcentrifuge tube. Each sample was vortexed for 2 min and centrifuged at 21,000 x g
for 4 min. The supernatant was carefully removed from solution and transferred to a clean, sterile
microcentrifuge tube. The pH of the supernatant was measured using Mettler Toledo model
attached with ORION ROSS perPHect pH electrode. The PZC was obtained from a plot of initial
solution pH versus pH of the supernatant.
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Figure A.1

SEM of Biochar. Different Views of BC Morphology.

(A) Black Owl Biochar, (B) BC in RPMI media, and (C) BC in RPMI media with E. coli. The
surface morphologies were studied at 5 kV acceleration voltage. The 20 μm scale in (A) applies
for all three panels.
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Figure A.2

The Average Point of Zero Charge (PZC) of BC and AC.

The initial pH is the pH of 0.1 M NaOH ranging from 2 to 12. Where the initial pH crossed the
average pH lines for BC or AC was determined to be the PZC. The PZC of BC (solid black line,
black dots) was determined to be 9.825. The PZC of AC (dotted gray line, gray triangles) was
determined to be 8.850. Error bars are the standard error of the mean of three identically
prepared samples. The standard error of the mean was less than 0.020.
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Figure A.3

Heatmap of Extracellular Metabolites in Unfiltered RPMI Media Arranged by
Classification.

Same heatmap presented in the Chapter 2 (Fig. 2.5), but the metabolites have been arranged by
classification instead of clustered using the Ward’s linkage algorithm. The row Z-score for each
feature was used to color code the map: absent to low concentration metabolites were colored
blue and high concentration metabolites were colored red.
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Figure A.4

Loading Plot of the Extracellular Metabolites in Unfiltered RPMI Media.

The significant metabolites (p < 0.05) in the loading plot are represented by the yellow dots
(significant metabolites). The significant metabolites are those that make the largest contribution
to each loading. The other metabolites in the loading plot are represented by the gray dots (other
metabolites). The other metabolites are those that contribution is not significant to each loading
and clustered around the points (0,0).
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Figure A.5

Statistical Analysis of E. coli Growth in Filtered RPMI Media.

(A) Principal component analysis (PCA) score plot on E. coli growth in filtered media was used
to identify statistically differences between each of the media types. The shaded oval represents
the 95% confidence limit for each media type (RPMI, blue circles; BC-treated media, green
circles; AC-treated media, red circles). Time points interval at every half hour are not labeled in
this figure for clarity. Data are the mean values of metabolite concentrations of three replicates
after being normalized using Pareto scaling. (B) The significant metabolites (p < 0.05) in the
loading plot overlay the PCA scatter plot on the biplot for filtered media. The yellow dots
represent the significant metabolites (p < 0.05), i.e. those making the largest contribution to each
principal component (RPMI, blue squares; BC-treated media, green diamonds; AC-treated
media, red triangles). (C) Heatmap of Extracellular Metabolites of Filtered Media. Heatmap of
the extracellular metabolite relative concentrations versus the time. The Pearson correlation of
the normalized, relative concentration was used to determine the distance measured. The row Zscore for each feature was used to color code the map. Absent to low concentration metabolites
were colored blue and high concentration metabolites were colored red. Ward’s linkage
algorithm ranked the metabolites in the clustering tree. The first 11 boxes (red) were labeled as
AC-treated media with the time increasing from 0 to 24 hours going left to right. The next 11
boxes (green) were BC-treated media and the last 11 boxes (blue) were RPMI media. All data
represent the mean values of concentration for 3 replicates after normalization and Pareto
scaling.
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Table A.1

Metabolite Concentration (mM) in RPMI Media.

Time (hours)
2-Hydroxyl-3methylbutyrate
2,3-Butanediol
2-Methylbutyrate
2-Oxoglutarate
4-Aminobenzoate
Acetate
Adenine
Cis-4-hydroxy-lproline
Citrate
D-Glucose
DL-4Hydroxyphenyllactate
Dihydroxyacetone
Ethyl-2-acetyllactate
acetate
Formate
Fumarate
Glycerol
Glycine
Isoamyl isovalerate
Isobutyrate
L-Alanine
L-Arginine
L-Aspartate
L-Asparagine
L-Cysteine
L-Cystine
L-Glutamate
L-Glutamine
L-Histidine
L-Isoleucine
L-Leucine
L-Lysine
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
Lactate

0

0.5

1

1.5

2

2.5

3

6

9

12

24

0.001

0.001

0.001

0.000

0.001

0.000

0.001

0.000

0.002

0.002

0.002

0.000
0.020
0.426
0.002
0.381
0.000

0.003
0.042
0.337
0.002
2.136
0.000

0.004
0.043
0.317
0.001
2.640
0.000

0.007
0.075
0.285
0.002
3.307
0.000

0.010
0.080
0.264
0.001
4.353
0.000

0.012
0.085
0.209
0.001
4.922
0.000

0.017
0.096
0.198
0.002
5.954
0.000

0.013
0.114
0.169
0.002
6.619
0.000

0.007
0.124
0.151
0.003
5.836
0.001

0.006
0.126
0.147
0.003
4.980
0.002

0.008
0.138
0.146
0.003
4.788
0.013

0.057

0.102

0.104

0.127

0.154

0.176

0.216

0.265

0.269

0.261

0.269

0.086
5.144

0.127
3.800

0.129
3.524

0.142
3.012

0.160
2.646

0.158
1.845

0.174
1.332

0.231
0.456

0.238
0.341

0.241
0.329

0.256
0.313

0.021

0.027

0.026

0.031

0.030

0.027

0.027

0.027

0.044

0.026

0.042

0.000

0.000

0.000

0.000

0.000

0.001

0.001

0.000

0.000

0.000

0.000

0.008

0.006

0.005

0.008

0.003

0.003

0.003

0.002

0.003

0.003

0.005

0.003
0.000
0.118
0.104
0.093
0.477
0.027
0.921
0.139
0.274
0.237
0.120
0.295
0.889
0.048
0.233
0.347
0.136
0.048
0.060
0.257
0.182
0.105
0.006
0.156
0.095
0.133

0.119
0.015
0.147
0.069
0.532
0.684
0.031
1.721
0.086
0.185
0.156
0.126
0.313
0.682
0.036
0.224
0.275
0.127
0.043
0.040
0.271
0.113
0.130
0.004
0.116
0.102
0.251

0.098
0.018
0.133
0.061
0.630
0.806
0.038
1.946
0.079
0.181
0.134
0.128
0.372
0.628
0.024
0.216
0.249
0.128
0.041
0.031
0.326
0.085
0.098
0.003
0.108
0.099
0.282

0.092
0.016
0.129
0.035
0.734
0.872
0.043
2.262
0.076
0.175
0.131
0.138
0.399
0.564
0.043
0.212
0.219
0.129
0.037
0.024
0.371
0.088
0.095
0.002
0.092
0.106
0.294

0.056
0.014
0.119
0.035
0.939
0.952
0.046
2.798
0.081
0.173
0.113
0.121
0.446
0.504
0.038
0.205
0.195
0.123
0.034
0.012
0.417
0.074
0.017
0.000
0.073
0.123
0.289

0.085
0.012
0.120
0.024
0.987
0.926
0.048
3.057
0.077
0.145
0.091
0.119
0.426
0.381
0.031
0.195
0.158
0.117
0.032
0.008
0.398
0.062
0.016
0.000
0.038
0.137
0.333

0.083
0.013
0.119
0.019
1.135
1.042
0.050
3.579
0.091
0.138
0.089
0.129
0.464
0.328
0.026
0.198
0.149
0.122
0.035
0.008
0.437
0.065
0.018
0.002
0.037
0.170
0.379

0.056
0.016
0.107
0.009
1.373
1.269
0.052
3.847
0.119
0.080
0.075
0.196
0.551
0.242
0.025
0.197
0.124
0.119
0.047
0.005
0.528
0.073
0.015
0.003
0.029
0.206
0.720

0.068
0.015
0.085
0.003
1.658
0.957
0.014
3.360
0.133
0.052
0.071
0.164
0.225
0.217
0.020
0.139
0.106
0.082
0.050
0.005
0.196
0.108
0.016
0.004
0.031
0.203
0.649

0.073
0.018
0.073
0.002
1.432
0.957
0.013
2.903
0.123
0.026
0.072
0.150
0.217
0.211
0.019
0.152
0.102
0.076
0.051
0.006
0.192
0.151
0.016
0.004
0.027
0.196
0.586

0.093
0.013
0.054
0.003
1.376
0.963
0.015
2.775
0.071
0.018
0.090
0.123
0.229
0.201
0.033
0.143
0.096
0.081
0.060
0.008
0.204
0.164
0.015
0.015
0.035
0.191
0.466

The bold metabolites and highlighted in light green at time point 0 h are the metabolites in RPMI
Media.
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Table A.1 (continued)
Time (hours)
Myoinositol
Pyruvate
α-Ketoisovalerate
Succinate
Uracil
Acetoin
Biotin
Choline Chloride
Ethanolamine
Nicotinate
Pantothenate
Thiamine
Riboflavin
Uridine

0

0.5

1

1.5

2

2.5

3

6

9

12

24

0.182
0.052
0.000
0.252
0.003
0.001
0.064
0.033
0.058
0.002
0.438
0.001
0.000
0.000

0.190
0.071
0.004
0.344
0.001
0.008
0.028
0.024
0.042
0.001
0.414
0.002
0.001
0.000

0.185
0.127
0.004
0.363
0.001
0.009
0.014
0.021
0.034
0.001
0.408
0.002
0.000
0.000

0.180
0.149
0.009
0.384
0.001
0.008
0.014
0.020
0.030
0.001
0.395
0.002
0.001
0.000

0.185
0.176
0.013
0.405
0.000
0.008
0.014
0.017
0.019
0.001
0.398
0.000
0.001
0.000

0.173
0.164
0.016
0.396
0.000
0.013
0.012
0.012
0.016
0.000
0.362
0.000
0.000
0.000

0.180
0.189
0.025
0.439
0.001
0.017
0.013
0.011
0.012
0.001
0.383
0.004
0.000
0.000

0.179
0.249
0.020
0.509
0.002
0.013
0.012
0.010
0.013
0.000
0.410
0.000
0.001
0.000

0.174
0.025
0.012
0.518
0.004
0.022
0.016
0.010
0.014
0.001
0.401
0.006
0.001
0.000

0.168
0.025
0.010
0.518
0.005
0.015
0.014
0.009
0.013
0.002
0.397
0.007
0.001
0.000

0.163
0.031
0.016
0.519
0.025
0.038
0.013
0.008
0.019
0.009
0.397
0.000
0.002
0.000

The bold metabolites and highlighted in light green at time point 0 h are the metabolites in RPMI
Media.
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Table A.2

Metabolite Concentration (mM) in BC Media.

Time (hours)
2-Hydroxyl-3methylbutyrate
2,3-Butanediol
2-Methylbutyrate
2-Oxoglutarate
4-Aminobenzoate
Acetate
Adenine
Cis-4-hydroxy-lproline
Citrate
D-Glucose
DL-4Hydroxyphenyllactate
Dihydroxyacetone
Ethyl-2-acetyllactate
acetate
Formate
Fumarate
Glycerol
Glycine
Isoamyl isovalerate
Isobutyrate
L-Alanine
L-Arginine
L-Aspartate
L-Asparagine
L-Cysteine
L-Cystine
L-Glutamate
L-Glutamine
L-Histidine
L-Isoleucine
L-Leucine
L-Lysine
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
Lactate

0

0.5

1

1.5

2

2.5

3

6

9

12

24

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.004

0.003

0.000
0.000
0.337
0.000
1.849
0.000

0.001
0.000
0.309
0.000
2.274
0.000

0.001
0.000
0.301
0.000
2.320
0.000

0.001
0.000
0.307
0.000
2.428
0.000

0.002
0.000
0.292
0.000
2.433
0.000

0.003
0.000
0.300
0.000
2.643
0.000

0.003
0.028
0.285
0.000
2.691
0.000

0.004
0.000
0.235
0.000
4.779
0.000

0.003
0.017
0.151
0.000
6.525
0.000

0.002
0.014
0.190
0.000
2.930
0.000

0.000
0.000
0.000
0.000
0.000
0.000

0.058

0.068

0.062

0.072

0.071

0.080

0.071

0.069

0.061

0.041

0.001

0.063
3.669

0.075
3.265

0.082
3.208

0.091
3.241

0.097
3.120

0.104
3.177

0.104
3.022

0.100
1.885

0.080
0.474

0.086
0.032

0.000
0.003

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.028
0.005
0.084
0.090
0.051
0.503
0.016
1.363
0.083
0.220
0.054
0.105
0.251
0.676
0.024
0.169
0.204
0.090
0.017
0.000
0.224
0.085
0.098
0.000
0.000
0.090
0.174

0.050
0.013
0.072
0.081
0.000
0.535
0.015
1.405
0.083
0.192
0.023
0.082
0.254
0.615
0.013
0.143
0.153
0.076
0.015
0.000
0.234
0.059
0.086
0.000
0.000
0.089
0.152

0.041
0.015
0.066
0.082
0.000
0.572
0.017
1.426
0.089
0.196
0.023
0.080
0.296
0.597
0.013
0.137
0.141
0.075
0.015
0.000
0.272
0.047
0.082
0.000
0.000
0.084
0.145

0.034
0.018
0.076
0.073
0.000
0.606
0.022
1.462
0.094
0.196
0.098
0.075
0.337
0.619
0.012
0.142
0.143
0.073
0.018
0.000
0.316
0.050
0.086
0.000
0.000
0.089
0.147

0.035
0.019
0.072
0.071
0.000
0.618
0.024
1.456
0.103
0.198
0.097
0.080
0.362
0.586
0.014
0.141
0.134
0.077
0.021
0.000
0.339
0.045
0.093
0.000
0.000
0.088
0.163

0.039
0.022
0.081
0.064
0.000
0.657
0.027
1.553
0.105
0.196
0.090
0.075
0.405
0.609
0.010
0.148
0.133
0.080
0.022
0.000
0.388
0.028
0.090
0.000
0.000
0.093
0.147

0.040
0.023
0.074
0.064
0.582
0.653
0.026
1.578
0.106
0.192
0.082
0.072
0.407
0.574
0.013
0.138
0.123
0.078
0.022
0.000
0.384
0.027
0.082
0.000
0.000
0.084
0.142

0.056
0.038
0.054
0.047
0.653
0.479
0.020
1.244
0.058
0.152
0.034
0.048
0.332
0.402
0.006
0.089
0.067
0.062
0.016
0.000
0.307
0.001
0.061
0.000
0.000
0.059
0.116

0.066
0.035
0.036
0.006
1.778
0.578
0.001
0.882
0.019
0.074
0.042
0.014
0.175
0.154
0.000
0.037
0.002
0.035
0.010
0.000
0.151
0.005
0.001
0.000
0.000
0.031
0.049

0.000
0.008
0.006
0.000
0.000
0.360
0.000
0.000
0.000
0.000
0.065
0.000
0.146
0.158
0.000
0.000
0.000
0.053
0.014
0.000
0.124
0.001
0.001
0.000
0.000
0.014
0.005

0.000
0.000
0.001
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.006
0.000
0.000
0.000
0.000
0.000
0.000
0.001
0.002
0.000
0.000
0.000
0.000
0.005

The bold metabolites and highlighted in light green at time point 0 h are the metabolites in RPMI
Media.
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Table A.2 (continued)
Time (hours)

0

0.5

1

1.5

2

2.5

3

6

9

12

24

Myoinositol
Pyruvate
α-Ketoisovalerate
Succinate
Uracil
Acetoin
Biotin
Choline Chloride
Ethanolamine
Nicotinate
Pantothenate
Thiamine
Riboflavin
Uridine

0.162
0.046
0.000
0.259
0.000
0.000
0.033
0.020
0.011
0.000
0.355
0.000
0.000
0.000

0.163
0.049
0.001
0.274
0.000
0.000
0.016
0.015
0.007
0.000
0.331
0.000
0.000
0.000

0.162
0.067
0.001
0.278
0.000
0.000
0.000
0.015
0.007
0.000
0.328
0.000
0.000
0.000

0.166
0.082
0.002
0.288
0.000
0.000
0.014
0.014
0.007
0.000
0.337
0.000
0.000
0.000

0.162
0.094
0.003
0.285
0.000
0.000
0.014
0.014
0.007
0.000
0.326
0.000
0.000
0.000

0.169
0.106
0.004
0.299
0.000
0.000
0.014
0.014
0.010
0.000
0.335
0.000
0.000
0.000

0.160
0.109
0.004
0.294
0.000
0.000
0.014
0.013
0.009
0.000
0.319
0.000
0.000
0.000

0.148
0.084
0.006
0.353
0.000
0.000
0.000
0.008
0.001
0.000
0.211
0.000
0.000
0.000

0.137
0.028
0.004
0.317
0.000
0.000
0.000
0.006
0.002
0.000
0.245
0.000
0.000
0.000

0.081
0.022
0.004
0.205
0.000
0.002
0.000
0.001
0.002
0.000
0.163
0.000
0.000
0.000

0.001
0.000
0.000
0.001
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000

The bold metabolites and highlighted in light green at time point 0 h are the metabolites in RPMI
Media.
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Table A.3

Metabolite Concentration (mM) in AC Media.

Time (hours)
2-Hydroxyl-3methylbutyrate
2,3-Butanediol
2-Methylbutyrate
2-Oxoglutarate
4-Aminobenzoate
Acetate
Adenine
Cis-4-hydroxy-lproline
Citrate
D-Glucose
DL-4Hydroxyphenyllactate
Dihydroxyacetone
Ethyl-2-acetyllactate
acetate
Formate
Fumarate
Glycerol
Glycine
Isoamyl isovalerate
Isobutyrate
L-Alanine
L-Arginine
L-Aspartate
L-Asparagine
L-Cysteine
L-Cystine
L-Glutamate
L-Glutamine
L-Histidine
L-Isoleucine
L-Leucine
L-Lysine
L-Methionine
L-Phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
Lactate

0

0.5

1

1.5

2

2.5

3

6

9

12

24

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000
0.009
0.254
0.000
0.900
0.000

0.001
0.000
0.175
0.000
1.569
0.000

0.000
0.000
0.139
0.000
1.503
0.000

0.000
0.000
0.138
0.000
1.615
0.000

0.001
0.000
0.139
0.000
1.604
0.000

0.001
0.009
0.121
0.000
1.474
0.000

0.001
0.000
0.130
0.000
1.653
0.000

0.001
0.000
0.025
0.000
1.467
0.000

0.001
0.000
0.019
0.000
1.658
0.000

0.001
0.000
0.000
0.000
1.695
0.000

0.001
0.000
0.000
0.000
1.734
0.000

0.045

0.041

0.037

0.040

0.038

0.038

0.041

0.034

0.037

0.035

0.037

0.064
2.669

0.052
1.902

0.045
1.682

0.051
1.774

0.054
1.863

0.051
1.716

0.058
1.888

0.053
1.732

0.054
1.749

0.054
1.779

0.055
1.722

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.013
0.002
0.041
0.078
0.045
0.287
0.009
0.698
0.120
0.201
0.085
0.063
0.180
0.517
0.012
0.096
0.119
0.068
0.019
0.000
0.167
0.104
0.094
0.000
0.007
0.072
0.140

0.026
0.007
0.026
0.058
0.240
0.295
0.006
0.901
0.091
0.147
0.021
0.031
0.161
0.349
0.000
0.055
0.048
0.037
0.008
0.000
0.149
0.118
0.073
0.000
0.000
0.055
0.100

0.025
0.006
0.019
0.054
0.000
0.265
0.006
0.851
0.084
0.125
0.050
0.027
0.149
0.283
0.000
0.043
0.035
0.025
0.007
0.000
0.140
0.098
0.062
0.000
0.000
0.049
0.089

0.032
0.007
0.019
0.052
0.253
0.292
0.005
0.732
0.091
0.128
0.048
0.022
0.173
0.284
0.000
0.042
0.029
0.023
0.009
0.000
0.161
0.107
0.064
0.000
0.000
0.048
0.090

0.036
0.007
0.019
0.057
0.000
0.321
0.005
0.200
0.089
0.126
0.012
0.020
0.187
0.286
0.000
0.039
0.024
0.016
0.008
0.000
0.175
0.113
0.061
0.000
0.000
0.043
0.088

0.039
0.008
0.016
0.051
0.000
0.292
0.005
0.589
0.088
0.117
0.021
0.017
0.175
0.248
0.000
0.036
0.019
0.014
0.009
0.000
0.164
0.110
0.058
0.000
0.000
0.040
0.080

0.045
0.008
0.020
0.054
0.000
0.326
0.005
0.000
0.093
0.122
0.011
0.018
0.193
0.269
0.000
0.036
0.017
0.012
0.008
0.000
0.182
0.115
0.058
0.000
0.000
0.042
0.084

0.068
0.010
0.010
0.041
0.000
0.307
0.005
0.372
0.086
0.097
0.014
0.014
0.188
0.200
0.000
0.027
0.003
0.003
0.007
0.000
0.176
0.103
0.050
0.000
0.000
0.023
0.069

0.107
0.011
0.011
0.040
0.234
0.311
0.005
0.452
0.094
0.088
0.013
0.011
0.192
0.172
0.000
0.026
0.001
0.002
0.004
0.000
0.183
0.108
0.049
0.000
0.000
0.022
0.068

0.143
0.012
0.012
0.040
0.000
0.311
0.005
0.000
0.093
0.078
0.000
0.014
0.187
0.150
0.000
0.021
0.000
0.000
0.000
0.000
0.178
0.107
0.043
0.000
0.000
0.015
0.069

0.262
0.014
0.015
0.031
0.000
0.313
0.004
0.000
0.086
0.048
0.000
0.022
0.172
0.107
0.000
0.022
0.000
0.000
0.000
0.000
0.163
0.114
0.044
0.000
0.000
0.010
0.081

The bold metabolites and highlighted in light green at time point 0 h are the metabolites in RPMI
Media.
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Table A.3 (continued)
Time (hours)
Myoinositol
Pyruvate
α-Ketoisovalerate
Succinate
Uracil
Acetoin
Biotin
Choline Chloride
Ethanolamine
Nicotinate
Pantothenate
Thiamine
Riboflavin
Uridine

0

0.5

1

1.5

2

2.5

3

6

9

12

24

0.146
0.034
0.000
0.144
0.000
0.000
0.0228
0.013
0.004
0.000
0.239
0.000
0.000
0.000

0.141
0.027
0.000
0.150
0.000
0.000
0.000
0.008
0.000
0.000
0.186
0.000
0.000
0.000

0.128
0.025
0.000
0.134
0.000
0.000
0.000
0.007
0.001
0.000
0.159
0.000
0.000
0.000

0.138
0.030
0.000
0.148
0.000
0.000
0.00789
0.008
0.001
0.000
0.169
0.000
0.000
0.000

0.139
0.031
0.000
0.165
0.000
0.000
0.000
0.008
0.000
0.000
0.177
0.000
0.000
0.000

0.131
0.029
0.001
0.150
0.000
0.001
0.0065
0.008
0.001
0.000
0.159
0.000
0.000
0.000

0.141
0.032
0.000
0.170
0.000
0.000
0.000
0.008
0.000
0.000
0.175
0.000
0.000
0.000

0.126
0.032
0.001
0.161
0.000
0.000
0.000
0.008
0.001
0.000
0.152
0.000
0.000
0.000

0.133
0.032
0.000
0.163
0.000
0.000
0.000
0.008
0.001
0.000
0.148
0.000
0.000
0.000

0.131
0.030
0.001
0.165
0.000
0.000
0.000
0.008
0.001
0.000
0.141
0.000
0.000
0.000

0.130
0.027
0.002
0.168
0.000
0.000
0.000
0.008
0.000
0.000
0.000
0.000
0.000
0.000

The bold metabolites and highlighted in light green at time point 0 h are the metabolites in RPMI
Media.
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APPENDIX B
SUPPORTING INFORMATION FOR INVESTIGATING THE KINETICS OF
PROTEIN COMPETITION ONTO NANOPARTICLE SURFACES
USING TWO-DIMENSIONAL NUCLEAR
MAGNETIC RESONANCE
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B.1
B.1.1

Supporting Materials and Methods
Dynamic Light Scattering
Dynamic Light Scattering (DLS) measurements were obtained for each protein and

mixture using Anton Paar Litesizer 500. The samples used in this experiment were the same
samples used in the NMR analysis; however, the NMR samples were diluted in half to get an
accurate measurement for the AuNP samples. Just the protein NMR sample concentration was 50
μM was 25 μM for the DLS, whereas the protein mixture concentration was in equal parts (25
μM Protein A and 25 μM Protein B for the NMR was 13.5 μM for each protein). The NMR
samples with AuNP concentrations were 80 nM (GB3-Ubq) or 60 nm (AM-R2ab), which would
have been too concentrated for the DLS measurements. The samples were transferred to a
disposable microcuvette for analysis. The average hydration diameter for each of the samples
were measured using the fitting function standard in the Kalliope software. For each
measurement, three independently prepared samples were measured, and the average value and
standard error of the mean is reported.
B.2

MATLAB Modeling
An in-house MATLAB script was created to kinetically model the protein competition on

the NP surface. The script uses a series of differential equations to generate curves to represent
how kinetics will alter the protein interaction onto the nanoparticle surface. The script considers
the initial concentrations (M) of the total protein, protein ratios, and the binding capacity for each
protein (N0A = 180.0*80.0x10-9= 1.44x10-5 and N0B = 158.0*80.0x10-9= 1.26x10-5). The k1 rate
is the forward kinetic reaction for either Protein A or B interacting with the soft corona, whereas
the k-1 rate is the reverse kinetic reaction for either Protein A or B interacting with the soft corona
138

and the local environment. The k2 rate is the forward kinetic reaction for either Protein A or B
binding in the hard corona and this reaction is irreversible. The terms AN and BN correspond to
Protein A or B interacting in the soft corona. The terms AH and BH correspond to Protein A or B
interacting in the hard corona.

𝑑[𝐴]
= −𝑘1𝐴 𝐴 𝑁 + 𝑘−1𝐴 [𝐴𝑁]
𝑑𝑡

(B.1)

𝑑[𝐵]
= −𝑘1𝐵 𝐵 𝑁 + 𝑘−1𝐵 [𝐵𝑁]
𝑑𝑡

(B.2)

𝑑[𝐴𝑁]
= 𝑘1𝐴 𝐴 𝑁 − (𝑘−1𝐴 + 𝑘2𝐴 )[𝐴𝑁]
𝑑𝑡

(B.3)

𝑑[𝐵𝑁]
= 𝑘1𝐵 𝐵 𝑁 − (𝑘−1𝐵 + 𝑘2𝐵 )[𝐵𝑁]
𝑑𝑡

(B.4)

𝑑[𝐴𝐻]
= 𝑘2𝐴 𝐴𝑁
𝑑𝑡

(B.5)

𝑑[𝐵𝐻]
= 𝑘2𝐵 [𝐵𝑁]
𝑑𝑡

(B.6)

𝑑[𝑁]
= −𝑘1𝐴 𝐴 𝑁 + 𝑘−1𝐴 𝐴𝑁 − 𝑘1𝐵 𝐵 𝑁 + 𝑘−1𝐵 [𝐵𝑁]
𝑑𝑡

(B.7)
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Figure B.1

GB3 and Ubq Hydrodynamic Diameter with 15 nm AuNPs.

Hydrodynamic diameter of GB3, Ubq, GB3-Ubq, AuNP, GB3-AuNP, Ubq-AuNP, and GB3Ubq-AuNP samples were measured using DLS. The hydrodynamic diameter showed a
monolayer protein corona on the AuNP surface (2*H.D.protein + H.D.nanoparticle). The error bars
represent the standard error of the mean of three independently prepared samples.
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Figure B.2

AM and R2ab Hydrodynamic Diameter with 15 nm AuNPs.

Hydrodynamic diameter of AM, R2ab, AM-R2ab, AuNP, AM-AuNP, R2ab-AuNP, and AMR2ab-AuNP samples were measured using DLS. The hydrodynamic diameter showed a
monolayer protein corona on the AuNP surface (2*H.D.protein + H.D.nanoparticle). The error bars
represent the standard error of the mean of three independently prepared samples.
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